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ABSTRACT 
 Arynes and heteroarynes are very important and useful reactive intermediates with 
many applications in organic synthesis, including natural products total synthesis. Although 
benzyne, the parent and most famous aryne, has itself been known for over 50 years, arynes 
derived from the ubiquitous indole nucleus were virtually unknown before our work.  
 The absence of these heteroarynes from the literature was surprising, given the 
potential utility of these reactive intermediates for an attractive entry into the indole alkaloid 
class of important and architecturally complex natural products. Some deceptively simple 
and other more unambiguously complex targets include such members as the trikentrins, 
herbindoles, teleocidins, nodulisporic acids, and penitrems to name just a few representative 
examples.  
 We discovered the first indole arynes, namely the 5,6- and 6,7-indole arynes (aka 
indolynes), and provided a vastly superior preparation of the 4,5-indole aryne as well as the 
iv 
 
others by devising a facile metal-halogen exchange and elimination protocol with 
o-dihaloindoles.  
 In addition to establishing the existence of these fascinating intermediates via 
trapping with their furan cycloadducts, we applied them to the successful total synthesis of 
several important, biologically active and challenging natural products including 
(±)-cis-trikentrin A, (±)-herbindole A, and (±)-herbindole B. These studies opened a 
successful strategy for the construction of natural products-inspired libraries based on this 
methodology.  
 We also conducted experimental and computational studies on the indole arynes that 
revealed, among other things, their unique properties and reaction profiles. The versatility of 
the 6,7-indole aryne in particular was evident in the many regioselective cycloadditions, 
ring-opening reactions, and rearrangements it exhibited. 
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CHAPTER 1. INTRODUCTION 
1.1 Benzynes: Preparation, Structure, and Reactivity  
Benzyne is a metastable aromatic species that is commonly represented by a 
didehydrobenzene structure that was first postulated as a reaction intermediate by Wittig in 
1942 (Scheme 1).
1
  
 
Scheme 1. Benzyne as a putative intermediate. 
However, Roberts is generally credited with the first successful preparation of benzyne 
itself and with the establishment of the “benzyne” (or more generally, aryne) mechanism by 
carbon isotopic labelling experiments in 1953 (Scheme 2).
2
  
 
Scheme 2. Roberts’ benzyne preparation and labelling experiment. 
2 
Following Roberts’ experiment, Wittig reported the first Diels-Alder reaction of benzyne 
with furan in 1955.
3
 This reaction became the most important reaction type not only in 
application to benzynes but also as a detector of benzyne intermediates.  
 
Scheme 3. Diels-Alder reaction of benzynes. 
Benzyne is usually represented by a benzene nucleus with a formal triple bond 1.3a, but 
the alternative depiction as a cyclic cumulene structure 1.3b is also widely used (Scheme 3). 
 
Scheme 4. Canonical representations of benzyne. 
Sometimes benzyne is drawn as a diradical canonical or resonance form 1.3e:  the pi bond is 
represented as having a single electron on each of two co-planar, adjacent orbitals. The most 
accurate electronic description (i.e., triple bond, cumulene, or diradical) is still the subject of 
contemporary investigations, and is influenced by specific electronic and substituent effects. 
The additional formal pi bond is localized and orthogonal to the other pi bonds that make up 
the aromatic ring. It is this additional strained formal pi bond that makes benzyne such as 
reactive intermediate. Unlike the ordinary pi bonds of acetylene in which the two sets of 
p-orbitals are parallel to each other and therefore maximize their overlap, the additional pi 
bond of benzyne has only partially overlapped sp
2
-like orbitals (e.g., see 1.3d, Scheme 4) that 
3 
is a necessary consequence of the benzene geometry. This partial overlap creates a very weak 
pi bond that renders benzynes extraordinarily unstable and highly reactive, even at low 
temperatures (e.g., -35 °C). 
The physical properties that support the structure of benzyne have been determined by 
numerous methods, including infrared
4-5
 and nuclear magnetic resonance spectroscopy.
6
  
For example Chapman reported the first IR spectrum of benzyne (generated via the 
photochemical decomposition of either phthaloyl peroxide or of benzocyclobutenedione) in 
an argon matrix at 8 K (Scheme 5).
4-5
  
 
Scheme 5. Chapman’s photochemical generation and trapping of benzyne in an argon matrix. 
The IR study revealed that benzyne exhibited key frequencies (e.g., 1627, 1607, and 
1451 cm
-1
) that were most consistent with a localized additional pi system which suggests 
that the triple bond canonical form is the best representation of the benzyne electronic 
structure. This assignment was supported by subsequent computational studies by Berry.
7
 
However, subsequent low temperature solution 
1
H and 
13
C NMR analyses by Cram and 
Warmuth of benzyne in a hemicarcerand (Scheme 6) concluded that the cumulene form was 
in fact the dominant mesomeric structure.
6
  
4 
 
Scheme 6. Photochemical generation and trapping of benzyne in a hemicarcerand. 
In addition to benzyne, or more formally ortho-benzyne (o-benzyne or 
1,2-didehydrobenzene), there are two additional types of benzynes that can be formally 
represented by diradicals, namely, meta-benzyne 7.1 (m-benzyne or 1,3-didehydrobenzene) 
and para-benzyne 7.2 (p-benzyne or 1,4-didehydrobenzene) (Scheme 7).  
 
Scheme 7. Ortho-, meta-, and para-benzyne. 
These other forms of benzyne have received comparatively little attention,
8
 and mainly 
from theoretical and spectroscopic studies.
9-23
 For example Jones has recently studied the 
interconversion of all three didehydrobenzenes (Scheme 8).
24-25
  
 
Scheme 8. Interconversion of the didehydrobenzenes. 
5 
The p-benzyne in particular is the putative intermediate in the Bergman cyclization of 
enediynes (Scheme 9).
26-27
   
 
Scheme 9. Bergman cyclization to 1,4-didehydrobenzene (p-benzyne). 
Ortho-benzynes, on the other hand, have been extensively studied, and have found many 
applications in organic synthesis since 1954.
2,28
  
 
Scheme 10. Reactions using benzyne as intermediate. 
For example, there are the Diels-Alder reactions with cyclic and acyclic dienes (10.1, 
10.2),
1
 [2+2] cycloadditions (10.3),
29-30
 1,3 and 1,4-dipolar cycoadditions (10.4, 10.5),
31-32
 
6 
ene-reaction (10.6),
33
 nucleophilic additions (10.7),
34
 Pd-catalyzed couplings (10.8)
35
 and 
[2+2+2] cycloadditions (10.9).
36
 The last two are three component addition reactions. The 
three component reactions have received more attention recently due to their high efficiency, 
and there are many variations of this type. 
There are many methods for the generation of benzynes reported in the literature 
(Scheme 11).  
 
Scheme 11. Common and useful methods for generating benzynes. 
The most synthetically useful methods are the dehydrohalogenation of halobenzenes 11.1
1,37
, 
metal-halogen exchange of o-dihalobenzene 11.2 and subsequent elimination,
38-40
 thermal 
elimination of o-diazonium carboxylates 11.3,
41
 lead tetraacetate oxidative  elimination of 
aminobenzotriazole 11.4,
42
 metal-halogen exchange and elimination of 
o-halophenylsulfoxide 11.5
43
 and o-halophenyl triflate 11.7,
44
 thermal decomposition of 
benzothiadiazole S,S-dioxide 11.6,
45
 and the fluoride induced decomposition of 
7 
o-trimethylsilylphenyl triflate 11.8.
46-47
 The last method, originally developed by Kobayashi, 
is the most common method for generating benzynes and other arynes under safe, mild, and 
economical conditions. 
There are few other arynes (excluding heteroarynes, vide infra) beyond benzyne itself 
and substituted benzynes. These include 1,2-didehydronaphthalene (1,2-naphthalyne) 12.1
48
 
and 2,3-didehydronaphthalene (2,3-naphthalyne) 12.2
49
 (Scheme 12) both of which were 
discovered and reported in 1958, and more recently, 4,5-tropyne 12.3,
50
 1,2-anthracyne 
12.4,
51-52
 1,2-phenanthryne 12.7,
36,51
 3,4-phenanthryne 12.8,
36
 9,10-phenanthryne 12.9,
36,51
 
2,3-didehydro-1,4-benzoquinone 12.5
53
 and 1,2-didehydrocorannulene 12.6.
54
 The literature 
reports involving the study of these systems are fairly scarce. They have not been exploited 
for natural products total synthesis. 
 
Scheme 12. Other common arynes. 
 
 
8 
 1.2 Heteroarynes 
Heteroarynes (also known as hetarynes) by contrast are defined as arynes with a 
heteroatom, usually nitrogen or oxygen, as part of the aromatic core. A few heteroarynes 
were known prior to this work. The oldest reference to a heteroaryne (although it was not 
characterized as such) was in 1902 by Stoermer and Kahlert who postulated a reactive 
intermediate with a formal triple bond within the furan moiety of benzofuran (13.1 Scheme 
13).
8
   
 
Scheme 13. Heteroarynes. 
Although the existence of this intermediate has never been established, other 
heteroarynes based on common heteroaromatic cores have been prepared. These include the 
pyridynes (2,3-didehydropyridine and 3,4-didehydropyridine),
55-56
 the quinolynes 
(2,3-didehydroquinoline and 3,4-didehydroquinoline),
57
 the thiophynes (2,3-thiophyne and 
3,4-thiophyne),
58-59
 1,2-didehydrothianaphthene
58
 and 1-Boc-3,4-pyryne.
60
 Of these classes 
of known heteroarynes, the pyridynes are by far more prevalent in the literature with about 
9 
200 references to date. Most of the citations involve theoretical and synthetic studies. As with 
the benzynes, recent experimental and theoretical studies concluded that the pyridynes also 
exhibit substantial triple bond and some diradical character.
61
 Both types of pyridynes have 
found applications in natural products total synthesis by way of their Diels-Alder reactions.
28
 
The 3,4-pyridyne has been generated via the fluoride-induced decomposition of the 
correspondoing o-silyl triflate.
62
 It has also been prepared by the lead tetraacetate oxidative 
elimination of 1-aminopyridinotriazole where it was used in a synthesis of isoindoles.
63
 An 
elegant and concise total synthesis of ellipticine by Castedo made use of a 2,3-pyridyne 
cycloadditon as the key step.
64
 Very recently Comins reported a five-step synthesis of the 
plant alkaloid macrostomine by a nicotine-derived 3,4-pyridyne.
65
 
Suprisingly, heteroarynes derived from the ubiquitous indole nucleus have received 
almost no attention (Scheme 14). 
 
Scheme 14. The tetrad of indole arynes (indolynes). 
Indoles are found in an enormous range of biologically active natural products and 
medicinally important agents. As such, this omission represents a major gap in the literature, 
and is therefore an important problem in organic chemistry. The first and only previous 
reports of an indole aryne (indolyne) were made by Igolen using a dehydrohalogenation 
method to generate presumably the 4,5 indole aryne followed by trapping with t-BuOH 
10 
(Scheme 15).
66
 However, no further investigations into these indole arynes were made until 
the Buszek laboratory published its seminal work beginning in 2007 (vide infra).
40,67-70
 
Interestingly, the elusive (and presumably far more strained) 2,3-indole aryne has the been 
the subject of intense studies by the Gribble laboratory for decades.
71-75
 
 
Scheme 15. Igolen’s synthesis preparation of a 4,5-indole aryne. 
Despite extensive work by that group, no conclusive evidence for the existence of this 
intermediate has been presented. 
The subject of the next and succeeding chapters of this dissertation will focus on the 
efforts to address this critical indole aryne chemistry problem. These efforts include the 
discovery of the heretofore unknown 5,6-, and 6,7-indole arynes, along with the development 
of general methods for the preparation of all of the benzenoid indole arynes (i.e., 4,5-, 5,6-, 
and 6,7-indolynes, but excluding the 2,3-indolyne of the pyrrole nucleus), their reactivity, 
theoretical and computational studies, applications for the total synthesis of complex natural 
products, and library development for the discovery of new bioactive compounds in 
medicinal chemistry.   
11 
Chapter 2. INDOLE ARYNES 
2.1 Preparation, Structure, and Reactivity 
Our interest in indole arynes initially grew out of a desire to use an aryne cycloaddition 
strategy as a means to gain rapid entry into the fascinating and important class of annulated 
indole alkaloid natural products such as the trikentrins, herbindoles, and teleocidins (Scheme 
16).  
 
Scheme 16. Annulated indole alkaloid natural products. 
12 
The trikentrins were isolated from the marine sponge Trikentrion flabelliforme in 1986 and 
showed antibacterial activity.
76
 Several years later, the structurally similar natural products, 
the herbindoles, were extracted from the Australian sponge Axinella sp., which possessed 
both cytotoxic and antifeedant properties.
77
 The teleocidins B families were first isolated 
from the Mycelia of Streptomyces mediocidicus by Takashima in 1962,
78-79
 and were found 
to be potent tumor promoters.
80-81
  
These deceptively simple compounds represent fantastic synthetic challenges, as 
evidenced by the large number of distinct approaches toward their total synthesis. We 
envisioned that a cycloaddition (e.g., Diels-Alder) strategy would offer the most direct 
method to install the annulated five- and six-membered aliphatic rings that comprise these 
architectures. Earlier strategies for the total synthesis of (±)-cis-trikentrin A relied on radical 
cyclization
82-84
 to form the indane skeleton followed by indole ring annulation. Subsequent 
total synthesis efforts for the trikentrins and herbindoles involved various diverse strategies 
which included intramolecular allene cycloaddition,
85
 heteroaromatic azadiene Diels-Alder 
reactions,
86
 intermolecular Heck coupling,
87
 intermolecular quinone monoimine Diels-Alder 
cyclization,
88-89
 electrocyclic divinylpyrroline ring closure,
90
 and ring contraction,
91
 whereas 
the enantioselective total synthesis of trikentrins and herbindole relied on pyrrole 
indolization
92-95
 or intramolecular allene cycloaddition strategies.
96
 The (±)-teleocidins B-3 
and B-4 have been synthesized by Nakatsuka in 1987
97
 and Okabe in 1991,
98
 via an 
acid-mediated Friedel–Crafts type of cyclization to form the quaternary center of the 
six-membered ring as the key step. However, all these approaches suffered from undesired 
13 
side reactions and low yields because of the strong acidic conditions. Very recently, Sames 
used Pd-catalyzed C-C bond coupling to access the stereogenic centers
99
 and Resnick used an 
intramolecular Heck reaction of a tetrasubstituted alkene to construct the teleocidins’ core.100 
However, neither of these two efforts resulted in a total synthesis of teleocidins B. 
We considered many methods for generating the indole aryne, including those discussed 
in Scheme 11. However, we elected the use the metal-halogen exchange/elimination aryne 
methodology
38-39
 for the indole systems because it was synthetically easier to access. The 
o-dihaloindole aryne precursors were readily prepared from commercially available 
o-dihaloanilines which would be used to synthesize the corresponding indole via the Fischer 
indole method (Scheme 17).   
 
Scheme 17. Retrosynthetic analysis of a Fischer route to the indolynes. 
 
 
2.2 Different ortho-Dihaloindoles and Their Reactions with Butyllithium 
The synthesis of indolyne precursors is described below. Commercially available 
3,4-dichloroaniline 18.1 was diazotized and reduced with stannous chloride in one pot to give 
the corresponding hydrazine in 77% yield.
101
 Condensation of 18.2 with phenylacetaldehyde 
under Fischer conditions with polyphosphoric acid afforded the expected 5,6-dichloroindole 
18.3 and 4,5-dichloroindole 18.4 as a 1:1 mixture with a total yield of 81%. After column 
14 
chromatography, methylation of the NH group gave the N-methyl indoles 18.5 and 18.6 in 
90% and 95% yield, respectively. With the desired aryne precursors in hand, many protocols 
for generating benzynes from ortho dihalo arenes were examined. 
 
Scheme 18. Fisher-indole synthesis. 
 All the attempted indole aryne generation reactions were run in diethyl ether solvent 
since some literature references
102-103
 suggested that there were dramatic solvent effects in 
polyhalobenzene metalation. Specifically, the diethyl ether solvent favored lithium-halogen 
exchange (at either halogen) while THF favored lithium-hydrogen exchange (i.e., 
deprotonation) adjacent to either halogen.  
The original intent was to generate the indole aryne in the presence of furan, which is 
considered the most efficient aryne trap known. In this manner, the existence of the indole 
arynes 19.1 or 19.3 would be inferred by the formation of the corresponding cycloadduct (see 
Scheme 21 later). 
Unfortunately, there was no apparent metal-halogen exchange between 18.5 and up to 
four equivalents of n-butyllithium, sec-butyllithium, or t-butyllithium even after several 
hours at room temperature. Surprisingly, only recovered starting materials were found in 
15 
each case. A similar observation was made with 18.6 in the case of the alkyllithiums n-BuLi 
and s-BuLi. However, the use of the stronger base t-butyllithium with 18.6 afforded a trace 
amount of a 1:1 mixture of the isomeric t-butylindoles 19.5 and 19.6 after one day, 
presumably via the 5,6-indole aryne. There is apparently no preference for nucleophilic 
attack at either position. It is still not clear whether the aryne formation was preceded by 
metal-halogen exchange at either C5 or C6. The same indolyne would be formed in either 
case.  
 
Scheme 19. First evidence for indolyne. 
A search of the literature revealed that there were only a few examples of 
o-dichlorobenzenes used as precursors to benzynes. Hales
104
 reported an interesting case in 
which hexachlorobenzene was used to generate, via metal-halogen exchange, the 
3,4,5,6-tetrachlorobenzyne which was in turn reacted with benzene itself to give 
tetrachlorobenzobarrelene. The general difficulty in obtaining indole arynes from their 
16 
o-dichloro precursors may be due to the low metal-halogen exchange rate which generally 
follows the order I > Br > H > Cl > F. 
103,105
 
Based on this trend, our next efforts at generating the required indole arynes involved the 
synthesis of other o-dihaloindole precursors such as those shown below via the same Fischer 
indole sequence shown earlier and using the commercially available o-dihalo anilines as 
starting material (Scheme 20).  
 
Scheme 20. Different o-dihaloindoles. 
Mixed o-dihalo arenes such as F and Br, or Cl and I are much more common aryne 
precursors.
39,103,106-107
 Similarly, dihalo arenes containing only fluorine or bromine are also 
found frequently in the literature.
39,105,107
  
With the desired compounds in hand, reaction of 20.1b under the previously described 
metal-halogen exchange conditions using t-BuLi in the presence of an excess of furan gave 
only the monofluoro indole 21.2 in 60% yield (Scheme 21).  An analogous result was 
obtained in 89% yield with compound 21.4. In both cases, lithium-bromine exchange 
apparently occurred preferentially, but was not followed by elimination to form the 
17 
corresponding indole aryne. The observation stands in contrast to what is known in simple 
benzene systems in which aryne formation occurs readily.
38,107
   
 
Scheme 21. Attempts at indolyne formation. 
While this outcome can be ascribed to the relatively poor leaving group ability of fluoride, 
the same trend was also seen with compound 20.3b. Although chloride was expected to be a 
better leaving group, only protonation of the lithio indole 21.5 was found in nearly 
quantitative yield. It is not possible to say with certaintly that this trend would stand with all 
possible o-FBr and o-ICl isomers since all of the needed o-dihalo aniline precursors were 
either not commercially available, or unknown in the literature. This remains an aspect of the 
indole aryne chemistry that requires further investigation. Even so, it is interesting to note 
that the trend of o-halolithium elimination (-LiX) in benzene is LiI < LiBr < LiCl < LiF.
108
 
However, a systematic study of the influence of other substituents in the benzene cases, has 
never been reported. It appears that the 4,5- and 5,6-dihaloindoles exhibit similar reactivity to 
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those of benzene. However, based on the data in hand, we decided to investigate the 
reactivity of o-dibromoindoles in all positions (the precursors for the o-diiodo cases are not 
known in the literature), and other readily available 6,7-dihaloindoles.  
Gratifyingly, evidence for the first successful indole aryne generation at the 6,7-position 
came from 6,7-dichloroindole 20.4b (Scheme 22). This compound was reacted with four 
equivalents of t-butyllithium to generate presumably the aryne 22.1, which underwent 
cycloaddition in the presence of an excess of furan to give the cycloadduct 22.2. However, 
this product was not stable to an excess of the alkyllithium reagent and experienced 
completely exo selective and regioselective SN2’ nucleophilic attack and ring opening to 
afford the observed product 22.3 as a single regioisomer in 78% yield. This process has 
ample precedent with many different nucleophiles, including hindered alkyllithiums.
109-110
 
The identity of compound 22.3 was confirmed unequivocally by 2D NMR analysis including 
COSY, NOESY, HMBC, and HSQC methods. Aromatization was induced by stirring in 
chloroform for several hours to give quantitatively the benzannulated derivative 22.4.  
 
Scheme 22. First successful generation of indolynes. 
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Repeating this sequence of reactions with only two equivalents of t-BuLi allowed for the 
isolation of the furan cycloadduct 22.2 in 31% yield (Scheme 23).  
 
Scheme 23. Isolation of 6,7-indole aryne cycloadduct with furan. 
Significantly, under these same conditions, a trace amount of the 6-chloroindole 21.6 was 
identified. Furthermore, no evidence for the formation of the 7-chloroindole was found. 
Together, these observations suggest that it is the 7-chloro position that undergoes 
completely selective lithium halogen exchange. Support for this claim is found in a recent 
literature case in which a pair of dibromoindoles, namely the 4,7- and 5,7-dibromoindoles, 
were found in each case to undergo lithium bromine exchange only at C7, followed by 
trapping with various electrophiles (Scheme 24).
111-112
 
 
Scheme 24. Selective lithium-bromine exchange. 
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Finally, the putative 6,7-indole aryne (6,7-indolyne) also reacted with 2,5-dimethylfuran 
to give the corresponding cycloadduct 25.1 (Scheme 25). 
111
   
 
Scheme 25. 6,7-Indole aryne reaction with 2,5-dimethylfuran and subsequent ring opening. 
This compound similarly reacted with an excess of t-BuLi, but now with an approximately 
equal mixture of regioisomers 25.2 and 25.3 being formed in a combined 84% yield. The 
difference in regiochemical outcome for these two reactions (e.g., Scheme 25) can perhaps be 
rationalized on the basis of ground-state destabilization. The opening of the furan 
cycloadduct 22.2 from the opposite side of the olefin would experience greater torsional 
strain thereby leading only to the observed product. This strain is significantly less 
pronounced from either direction with 25.1, owing to the presence of the larger methyl 
groups, and a statistical distribution of products is found instead. The issue of regiocontrol in 
these systems remains the subject of further investigation. 
 Although only the 6,7-indole aryne could be prepared within the o-dichloroindole series, 
we were gratified to discover that all three benzenoid indolynes could be generated easily and 
trapped as their Diels-Alder cycloadducts in good yields from the o-dibromoindole 
precursors. Our first attempt paralleled that of the 6,7-dichloroindole work (Scheme 26). 
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Scheme 26. General route to all three benzenoid indole arynes. 
Thus, the aryne precursor 20.7b was treated with four equivalents of t-BuLi in ether in 
the presence of an excess of furan to give a complex mixture of products 22.2 – 26.2. The 
cycloadduct 22.2 was a minor component of this mixture for reasons that are analogous to the 
6,7-dichloroindole case. The excess t-BuLi attacks the cycloadduct in the same exoselective 
and regioselective fashion to afford 22.3 as the major product. In addition, the t-butylated 
indole 26.1 likely arises from the regioselective nucleophilic attack at the 6-position on the 
6,7-indolyne. Finally, the trace amount of 26.2 can be rationalized by the sequential 
lithiation-protonation of the 6,7-dibromoindole. 
 The use of n-butyllithium in place of the more reactive and nucleophilic t-butyllithium 
reagent during the indole aryne generation step permitted the isolation of all the furan 
cycloadducts (Scheme 27). In fact, it was found that only a slight excess of n-BuLi in ether 
was necessary to effect these transformations. The process can be envisioned as follows. 
Selective lithium-bromine exchange of the 6,7-dibromoindole 20.7b gives the intermediate 
27.1 which upon warming undergoes elimination to generate the 6,7-indole aryne 22.1. 
Subsequent cycloaddition with furan readily affords the corresponding cycloadduct in good 
yield. Support for this view is provided by the minor amounts of compound 27.2 which 
clearly reveals an intial exchange at C7, and 27.3 which in turn suggests that the 6,7-indolyne 
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is a highly polarized aryne that directs nucleophiles such as n-BuLi to the more 
electropositive 6-position exclusively. 
 
Scheme 27. General method for generating 4,5-, 5,6-, and 6,7-indole arynes. 
In a similar manner, the 4,5- and 5,6-indole arynes were generated from their corresponding 
o-dibromo precursors and trapped with furan to afford the respective cycloadducts is 
excellent yield. With these latter two cases, no evidence of the n-butylated indoles was 
found.  
Reaction of the 4,5- and 5,6-indole arynes with 2,5-dimethylfuran gave excellent yields 
of the corresponding cycloadducts (Scheme 28). 
 
Scheme 28. Reaction of 4,5- and 5,6-indole arynes with 2,5-dimethyl furan. 
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Finally, it was found that reaction of the 4,5-indole aryne with cyclopentadiene also 
occurs readily to give the cycloadduct in very good yield (Scheme 29). 
 
Scheme 29. Reaction of a 4,5-indole aryne with cyclopentadiene. 
By contrast, the corresponding reaction with the 6,7-indole aryne produced very little of 
the desired cycloadduct (Scheme 30). Again, it is tempting to speculate that the proposed 
polarized structure of the 6,7-indolyne might cause deprotonation of cyclopentadiene by the 
C7 carbon of the aryne. The fact that this was not observed with the 4,5-indole aryne 
suggests that it behaves more like benzynes and that this reactive intermediate has in fact 
more triple bond or diradical character. However, changing the solvent from diethyl ether to 
toluene allowed the 6,7-indole aryne reaction with cyclopentadiene to proceed normally.  
 
Scheme 30. Reactions of indole arynes with cyclopentadiene. 
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Coe reports that the less polar hydrocarbon solvent promotes metal-halogen exchange and 
suppresses the undesired acid-base reaction. 
113
 
Finally, we observed that ortho difluoroindoles exhibit anomalous behavior upon 
treatment with t-butyllithiums (Scheme 31). It is known that the more electropositive 
halogens undergo the most rapid metal-halogen exchange, and this was indeed found to be 
the case with the bromo indole series. In the fluorine system, the isomeric 4,5- and 
6,7-difluoroindoles gave only recovered starting material under these same conditions. The 
reaction of 5,6-difluoroindole 20.9b with n-BuLi, however, gave exclusively the cycloadduct 
31.3 in 80% yield. 
 
Scheme 31. Indolyne generated from t-BuLi and difluoro-indole. 
Initial deprotonation of the thermodynamically more acidic C7 hydrogen as a result of the 
inductive electron withdrawing effect of the adjacent nitrogen as well as the electronegative 
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fluorine atoms leads to aryne formation. This assumption is also consistent with 
well-documented observation that the rate of transmetallation of fluorine is slow compared 
with deprotonation at the ortho position.
102-103,111,114-117
  Trapping and cycloaddition with 
furan thus gave the observed cycloaddduct, and 
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F NMR revealed one remaining fluorine at 
the C5 position. 
In conclusion we have provided the first evidence for the existence of all three isomeric 
indole arynes in the benzenoid core using a practical and general method. The facile 
generation of aryne indoles from dibromoindoles in particular is noteworthy for its synthetic 
simplicity and good yields. This discovery adds indoles to the suite of aromatic systems from 
which arynes can be easily and readily generated.  
Bromine is a better exchanging and leaving group for indolyne, no matter where the 
position is. Chlorine and fluorine are usually not active enough to form indolyne, but may do 
the job with some particular positions. The 6,7- bond in the indole ring has a very unique 
property, which can assist in indolyne generation. t-butyllithium is a stronger base for our 
reaction, but n-butylithium gave us cleaner and more reproducible results. 
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CHAPTER 3. INDOLE ARYNE PROPERTIES AND REACTIONS 
3.1 Regioselective Diels-Alder Cycloaddition of Indolyne 
During the course of the indole aryne investigations, several interesting and surprising 
phenomena came to our attention. The first one involved an unexpected and highly 
regioselective Diels-Alder cycloaddition with the 6,7-indole arynes and 2-t-butylfurans 
(Scheme 32). 
 
Scheme 32. The 6,7-indole aryne regioselective cycloadditions. 
Thus, it was found that reaction of the 6,7-indole aryne derived from the dibromoindole 
20.7b with 2-t-butylfuran gave mainly a single regioisomer along with a minor product. 
NMR analysis of the separable mixture revealed a surprising outcome in which the more 
sterically crowded regioisomer, (i.e., the contrasteric product), 32.2a was identified as the 
major isomer.  This phenomenon was observed with other 2-substituted furans with 
somewhat diminishing levels of regiocontrol through the series i-propyl, ethyl, and methyl. 
This trend correlates regioselectivity with the degree of branching at the point of substitution 
(Table 1). 
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Table 1. Regioselective 6,7-indolyne cycloadditions with 2-substituted furans. 
 
entry R Yield (%) Ratio (a:b) 
1 Me 89 80:20 
2 Et 90 84:16 
3 i-Pr 88 94:6 
4 t-Bu 91 98:2 
5 Ph 92 >99:1 
6 SO2Ph 83 <1:99 
Additionally, there was virtually complete regiocontrol in the case of 2-phenylfuran. A 
simple first-order resonance structure analysis rationalizes this behavior in terms of a 
polarized 6,7-indole aryne combining with the furan in such a way that the more highly 
stabilized cation in 32.7 preferentially bonds to C7 (Scheme 32). The more highly branched 
substituent is more electron rich and therefore better able to stablize by induction an adjacent 
positive charge. The virtually complete regiocontrol with the 2-phenylfuran can clearly be 
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understood in these terms. This analysis predicts that electron withdrawing substituents at the 
2-position in the furan should give the opposite regiochemistry. Indeed, this was found to be 
the case (entry 6, Table 1). Thus, the 2-phenylsulfonylfuran gave a >99:1 ratio of isomers 
favoring the reverse regiochemistry. In earlier studies by other laboratories involving the 
reaction of monosubstituted 3-benzynes with 2-substituted furans (Me, Et, i-Pr, and 
t-Bu),
117-119
 regioselectivity correlated well with the strength of inductively 
electron-withdrawing groups such as F and OMe on the benzyne to favor the contrasteric 
products. It was reversed with inductively electron-donating groups such as Me (Scheme 33). 
 
Scheme 33. Polarization effects and regioselectivity. 
 This regiocontrol however was specific to the 6,7-indole arynes. The corresponding 4,5- 
and 5,6-indolynes showed no regioselectivity with 2-t-butylfuran, giving a 1:1 mixture in 
each case.  
 
Scheme 34. The 4,5 and 5,6-indole aryne cycloadditions with 2-t-butylfurans. 
29 
To characterize this phenomenon in additional detail, electronic structure calculations 
were undertaken in collaboration with Professor Christopher Cramer and his research group 
(Department of Chemistry and Supercomputing Institute, University of Minnesota) to predict 
the structures and reactivities of the N-methyl-4,5-, 5.6-, and 6,7-indolynes with furan and 
2-alkylfurans.
40
 With respect to the methodology, all of the structures were optimized using 
the M06-2X density functional
120
 and 6-311+G(2df,p) basis set
121
 as implemented in 
MN-GFM,
122
 a locally modified version of the Gaussian03 software package.
123
 Analytical 
frequency calculations were employed to characterize the nature of all gas-phase structures as 
minima or transition states. In select instances, the effects of diethyl ether solvation were 
taken into account using the SMD
124-125
 implicit solvation model. 
The calculations support the view that the 6,7-indolyne (but not the 4,5- and 
5,6-indolynes) is highly polarized in the manner previously shown (Scheme 27). The fact that 
the C6 position is substantially more electrophilic than the C7 position comes from 
inspection of atomic polar tensor partial charges and the molecular geometry. Thus, C6 is 
predicted to have a charge 0.26 au more positive than C7, and the C5-C6-C7 bond angle is 
predicted at the M06-2X level to be 135.3° while the C6-C7-C7a angle is predicted to be 
117.2°. The former value is more consistent with carbocationic character, while the latter is 
more consisten with carbanionic character. Thus, the C6-C7 bond is strongly polarized in the 
expected direction by the nearby C7a-N bond dipole. 
Table 2 lists the activation free energies computed for the reaction of the 
N-methylindolynes with the furans.  
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Table 2. ∆Gǂ values in kcal/mol for the reaction of indolynes with substituted furans. 
 
entry aryne furan, R ∆Gǂ (a) ∆Gǂ (b) 
1 2-1 H 10.5  
2 2-2 H 10.0  
3 2-3 H 8.7 (8.4)
a 
 
4 2-1 t-Bu 6.3 7.3 
5 2-2 t-Bu 6.9 6.1 
6 2-3 t-Bu 7.0 (8.0) 
b 
7 2-3 Me 9.2 (9.4) 7.5 (7.8) 
8 2-3 Et 9.0 (9.4) 7.8 (8.2) 
9 2-3 i-Pr 9.7 (10.3) 7.6 (8.2) 
a
 Values in parentheses include continuum ethereal solvation effects. 
b
 No barrier to reaction is predicted in the gas phase or continuum solution. 
With unsubstituted furan, DG is similar for the 4,5- and 5,6-indolyne isomers, and slightly 
smaller for the 6,7-isomer. Considering 2-t-butylfuran, the predicted free energies of 
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activation are reduced by 3-4 kcal/mol compared to the reaction with furan itself in the 4,5- 
and 5,6-indolyne cases. Regioselection becomes possible upon 2-substitution of the furan, 
and the differential free energies of activation in these two instances are predicted to be 1 
kcal/mol or less. In the 6,7-indolyne case, by constrast, a free energy of activation similar to 
those for 4,5 and 5,6 is predicted for the formation of 2-6a, but no transition-state (TS) 
structure for the formation of 2-6b could be located. The approach of the furan to the 
indolyne led smoothly and without barrier to the final tertacyclic product every time. 
 Thus, the electron-poor indolyne attacks the 2-substituited furan to generate the more 
stable 2-alkyldihydrofurylcarbenium ion. As the 2-substituent is varied from Me to Et to i-Pr, 
the increased stabilization provided by the larger alkyl groups leads to increased 
regioselection and increased electrophilic substitution character so that bond formation 
becomes decreasingly synchronous. It appears in the case of R = t-Bu the combination of 
unavoidably increased sterics and enhanced carbenium ion stabilization switches the 
mechanisms for a highly asynchronous but still concerted cycloaddition (e.g., Diels-Alder) to 
a stepwise electrophilic substitution and subsequent ring closure. The term “stepwise” is used 
with a degree of caution in this context since no TS structures or intermediates were located 
in either the gas phase or ethereal continuum solution for this process. To the extent that the 
reaction has an actual free energy of activation, it is likely associated with the displacement 
of discrete solvent molecules between the indolyne and furan reaction partners that was not 
included in the computational models used for this analysis. 
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A very interesting observation was made when we examined the Diels-Alder reaction of 
the unprotected indolyne 35.1 and cyclopentadiene. We found in this case that the 
7-butylindole 35.3 was the major product (Scheme 35). 
 
Scheme 35. Different regioselective products. 
The same outcome was observed whether an excess amount of n-BuLi was used to 
deprotonate the indole N-H group, or whether the anion was preformed with NaH, followed 
by metal-halogen exchange. This results stands in contrast to the observation that 
6-butylindole 33.1 was usually the only byproduct when N-methylindole 34.6 was the 
substrate. This interesting observation suggested that the regioselective reaction of 
6,7-indolyne and nucleophilic compound could be reversed by the electronic properties of the 
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nitrogen atom in the indole aromatic ring system. A computational analysis of this 
phenomenon is underway. 
 
 
3.2 6,7-Indole Aryne Ene Reaction 
In connection with several other planned total synthesis objectives (e.g., teleocidins), we 
were interested in examining the behavior of 6,7-indole arynes with acyclic dienes. These 
cycloaddition partners are known to give different products with benzynes depending on a 
number of parameters,
33,126
 but their reaction with indolynes was clearly not investigated. 
When we examined the scope of the Diels-Alder reaction between various dienes such as 
isoprene, 2,3-dimethyl-1,3-butadiene, and -terpinene and the 6,7-indolyne, we also obtained 
unexpected results. While we were anticipating the formation of some [4+2] product, it 
turned out that dienes that possess allylic hydrogens gave only the corresponding ene 
products as the major component of the complex mixture (Scheme 36). Despite the generally 
good yields obtained in each case, no Diels-Alder products were identified in these examples. 
Interestingly we actually obtained about 30% of the Diels-Alder product when we used 
1,3-cyclohexadiene instead of α-terpinene.   
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Scheme 36. Ene reactions between dienes and indolynes. 
 The reaction between α-terpinene and 6,7-indolyne is especially noteworthy. Although 
the ene reaction was a fairly common by-product in many Diels-Alder reactions between 
dienes and benzyne, it always appeared as a minor product when the diene was cyclic.
33,126
 
Only when allylic olefins are used instead of dienes does the ene reaction with benzyne 
become a synthetically useful process. There is much literature to support the concerted 
mechanism for the benzyne ene reaction,
33,127
 but there is still no completely satisfactory 
explanation for the competition between the [4+2] and ene reaction.  
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 Crews reported the cycloaddition of benzyne with isoprene and 1,3-cyclohexadiene 
(Scheme 37). 
33,126
 
 
Scheme 37. Crews’ results. 
This method for benzyne generation required elevated temperatures to decompose the 
o-diazonium carboxylate, and in these cases there was a high percentage of [4+2] products 
found. Comparing these results to our work in which the indolyne was generated at low 
temperature (typically aryne formation occurs at approximately -35 °C), we believe that 
temperature played a important role in the competition between [4+2] and ene reaction. It is 
well known that the s-trans-butadiene is the much more stable of the two rotamers of 
1,3-butadiene, but s-cis butadiene is the one that participates in Diels-Alder reaction. At room 
temperature, these two isomers will interconvert very rapid, but at -78 ºC, the equilibrium 
clearly favors the s-trans population. For isoprene, the Crews experiment was conducted at 
50 ºC which would give more s-cis diene for Diels-Alder reaction, while our reaction was run 
at -78 ºC which would favor the ene reaction. For α-terpinene, the ene reaction would let the 
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diene approach to indolyne from a less stereo chemically hindered position, thus 
1,3-cyclohexadiene would favor the Diels-Alder reaction while α-terpinene would favor the 
ene reaction (Scheme 38). 
The regioselectivity in all of the 6,7-indole aryne ene reactions can be rationalized by 
polarization as shown in Scheme 36. 
 
Scheme 38. Proposed explanation for ene vs Diels-Alder. 
 
 
3.3 Selective Ring Opening Reaction 
During the research into the Diels-Alder reaction with indolynes, we also found several 
interesting and potentially useful ring opening and rearrangement reactions with the initial 
cycloadducts. These phenomena were observed mainly with the products obtained from the 
6,7-indole aryne cycloadditions. The first observation came from the 2-t-butylfuran 
cycloadduct 32.2a.  After purification via column chromatography and confirmation of its 
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identity by NMR, we noticed this compound began to rearrange slowly upon standing in 
CDCl3. After just ten minutes, a new component was present, which increased in proportion 
over time. After seven hours compound 32.2a disappeared and was replaced by a new single 
compound which was established unequivocally to be the ring opened annulated enone 39.1. 
 
Scheme 39 Ring opening reaction. 
The appearance of 39.1 was unexpected, since the literature regarding the acid catalyzed 
ring opening of furan Diels-Alder products shows that they normally result in benzannulation 
to afford naphthalenols 39.4.
118
 In an effort to better understand the mechanism of this 
process, compound 32.2a was reacted with various acids under different conditions. The 
results are summarized in Scheme 40.   
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Scheme 40. Different ring opening products from different acidic catalysts. 
With strong acids such as TsOH or 3M ethereal HCl to open the ring, the initial product 
was again 39.1 but it reacted further under these conditions and rearranged to the phenol 
product 40.2. Giles reported that naphthalenes containing isopropyl and t-butyl substituents 
in a peri relationship to another substituent are prone to undergo ready protodealkylation.
118
 
In our case, because of the steric hindrance between the t-butyl group and the N-methyl 
group, this protodealkylation became even more facile. The appearance of the 
naphthoquinone byproduct 40.1 was also unexpected, but it can also be explained in terms of 
39 
the release of strain with the N-methyl substituent caused by the t-butyl group. Compound 
40.1 was only found when the reaction was run in air, and was totally absent when the same 
experiment was conducted under an inert atmosphere such as nitrogen or argon. Moreover, 
40.1 was the only product when PPTS was used as the catalyst but it could not be generated 
from 39.1 by further acidic catalysis (Scheme 40). Together these data indicate that 
compounds 40.1 and 40.2 arise from different mechanisms from 32.2a, and that neither 
compound 39.1 or 40.2 is intermediate in the pathway that leads to the formation of the 
naphthquinone (Scheme 41). 
 
Scheme 41. Reaction direction between different products. 
Aluminum chloride was an effective catalyst for effecting the transformation of 32.2a to 
39.1 without further rearrangement. Although the reason for this is not fully understood at 
present, we believe that the coordination of the C=O group to the Lewis acid aluminum 
chloride somehow prevents further aromatization.  
40 
 
Scheme 42. Coordination between C=O and AlCl3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
41 
CHAPTER 4. APPLICATIONS OF INDOLE ARYNES  
4.1 Retrosynthesis and Preliminary Experiments of (±)-cis-Trikentrin A and 
(±)-Herbindole A and B 
Since we discovered the new class of aryne derived from all three benzenoid positions of 
the indole nucleus and obtained their cycloadducts with furan successfully, we wanted to 
adapt this approach to the synthesis of complex natural products.  The annulated indole 
alkaloid natural products should be especially amenable to this strategy. An intermolecular 
indolyne cycloaddition approach should provide a rapid entry into annulated indole natural 
products including cis-trikentrin A, herbindole A and herbindole B. The retrosynthetic 
analyses of these three natural products are very straight forward (Scheme 43).  
  
Scheme 43. Retrosynthetic analysis of the (±)-cis-trikentrin A, (±)-herbindole A, and 
(±)-herbindole B. 
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The annulated cis-disubstituted cyclopentane would be installed via the Diels-Alder reaction 
of cyclopentadiene and 6,7-indole aryne. The aryne precursor, namely, 6,7-dibromoindole, 
was synthesized via the Bartoli reaction starting from the commercially available aniline. 
Before the total syntheses of these natural products were undertaken, a Diels-Alder 
reaction of the 6,7-indolyne and cyclopentadiene (Cp) was run to optimize this key step. In 
this preliminary experiment, 6,7-dibromo-1-methyl-3-phenyl-1H-indole 20.7b was chosen as 
the starting material, and the standard reaction conditions were adopted as before: Thus, the 
6,7-dibromoindole was dissolved in ether with 20 eq Cp, cooled to -78 ºC, then treated with 
1.1 eq n-BuLi, and the mixture raised to room temperature over 1 h. The first run gave a 
complex mixture, including 13% cycloadduct 30.1, 26% of the 6-bromoindole 27.2, and the 
remainder mostly starting material. 
This result could be rationalized by the competition from acid-base reaction of 
cyclopentadiene and n-BuLi as Coe found in trihalobenzenes.
113
 This acid-base reaction 
would deprotonate cyclopentadiene leading to the stable aromatic anion, thus suppressing its 
[4+2] cycloaddition with 6,7-indole arynes. Some improvement was obtained when the 
concentration of Cp was reduced to 2 eq in order to limit the otherwise favorable kinetics of 
the acid-base reaction (Table 3, entry 3). Interestingly, it was found that when n-BuLi was 
added first and allowed to mix with the dibromoindole for 10 minutes prior to Cp addition, 
almost no cycloadduct was detected, and much more 6-bromoindole was obtained (Table 3, 
entry 2).  
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Table 3. The yields of cyclopentadiene addition to 6,7-indole aryne under different 
conditions.
a 
 
Entry 
Cp 
(eq) 
n-BuLi 
(eq) 
Solvent T (ºC) 
Yield (%) Products distribution 
30.1 30.1 27.2 27.3 20.7b 
1 20 1.1 Et2O -78 to rt 13 13 26 0 61 
2 20 1.1 Et2O -78 to rt 0
 b
 0 34 0 52 
3 2 2 Et2O -78 to rt 19 23 49 0 28 
4 1.5 1.5 Et2O 0 to rt 20 12 6 6 48 
5 1 1 PhMe 0 to rt 20 46 0 13 41 
6 2 2 PhMe 0 to rt 70 70 5 25 0 
7 2 2 
Petroleum  
ether 
0 to rt 20 58 0 27 14 
8 2 2 PhMe -78 to rt 88 88 0 12 0 
a 
General procedure: The 6,7-dibromoindole and cyclopentadiene (Cp) were dissolved in the 
indicated solvent, and the temperature lowered to -78ºC in a cold bath (dry ice/acetone), then 
n-BuLi was added into the mixture and stirred for 30 minutes. The cold bath was removed 
and the reaction mixture raised to room temperature over 1 h, followed by a standard organic 
work up. 
b
n-BuLi was added at -78ºC, stirred for 10 min, then cyclopentadiene was 
introduced to the mixture and reacted as usual. 
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Decreasing the temperature at which the reaction was started reduced the byproduct 
6-butylindole 27.3 by generating indole arynes at a lower rate (Table 3, entry 6 and entry 8). 
The most important factor for this reaction was solvent. After we changed the solvent from 
diethyl ether to toluene, the yield of cycloadduct increased from 20% to 70% dramatically. 
Protonation was suppressed in toluene, and the result was a corresponding higher yield of the 
desired cycloadduct as reported by Coe with simple benzynes. The best yield (88% isolated 
yield) of 30.1 was obtained with 2 eq cyclopentadiene and 2 eq n-BuLi at -78ºC to rt with 
toluene as the solvent. 
 
4.2 Synthesis of (±)-cis-Trikentrin A 
With the key cycloaddition step optimized in a model system, we embarked on the 
synthesis of (±)-cis-trikentrin A. The first objective was the to make the 6,7-dibromoindole 
precursor. We originally prepared dihaloindoles from the o-dihalohydrazines via Fischer 
indole chemistry. However, repeated efforts to synthesize o-dihaloindoles unsubstituted at 
the 2- and 3-position via Fischer chemistry gave disappointing results. Our revised plan was 
influenced by Bartoli’s observation that such unsubstituted indoles can be obtained in good 
yields from the reaction of nitrobenzenes and vinyl Grignard reagents.
128-131
 The synthesis of 
trikentrin A thus began with commercially available 4-ethylaniline 43.2 (Scheme 45). 
Nitration was accomplished in 96% yield in one pot by a literature procedure.
132
 
Diazotization with t-BuONO followed by bromination catalyzed by CuBr2 was carried out in 
45 
82% yield to afford the o-dibromide 45.2.
133
 Application of the Bartoli indole synthesis 
(CH2CHMgBr, 3 equiv; THF, -40 °C) proceeded uneventfully and gave the desired indole 
35.1 in 52% yield.  
 
Scheme 44. cis-Trikentrin A: Bartoli indole synthesis. 
 In other cases reported by Bartoli, highly variable yields were found only with 
o-substituted nitrobenzenes. We were able to find only a few other examples of trisubstutited 
nitrobenzenes and no examples of 2,3-dihalo nitrobenzenes used in this procedure.
128
 By 
comparison, the best indole synthesis yield reported by Bartoli is 67% with 2-methyl 
nitrobenzene.
131
 The N-H group of the indole was then protected as its TBS group (KHMDS, 
TBSOTf, THF, -78°C) in 73% yield. Attempts to carry out the cycloaddition with the 
unprotected indole N-H or its anion with various simple counterions (Li
+
, Na
+
) met with 
failure. 
The Diels-Alder reaction between the N-protected indolyne precursor 45.3 with Cp under 
the optimized reaction conditions in toluene smoothly and cleanly gave the desired 
cycloadduct 46.1 in 77% isolated yield. Osmylation of 46.1 (cat. OsO4/NMO, THF/H2O, 9:1) 
followed by oxidative cleavage of the diol 46.2 (NaIO4, THF/H2O (3:1)) afforded the 
46 
dialdehyde 46.3 in 87% yield for the two steps. Several methods were attempted for 
converting the dialdehyde into the required cis dimethyl groups, including Wolff-Kishner 
reduction, without success. Finally, 46.3 was converted into its corresponding dithioacetal 
46.4 (excess EtSH, BF3·OEt2, -78 °C) with concomitant desilylation in 91% yield. Raney 
nickel reduction afforded in nine steps synthetic (±)-cis-trikentrin A, which was identical in 
all respects to the physical data reported for this racemic compound.
76
  
 
Scheme 45. cis-Trikentrin A: 6,7-indolyne tactic. 
  
 
4.3 Synthesis of (±)-Herbindole A 
Encouraged by the success with the trikentrin synthesis, we turned our attention to the 
total synthesis of the structurally related herbindole A (Scheme 46). The synthesis of 
herbindole A entirely parallels that of of cis-trikentrin A. The intriguing issue presented by 
47 
this synthesis was whether for electronic and steric reasons the required tetrasubstituted 
nitrobenzene would be viable as a substrate in the key Bartoli step.  
 
Scheme 46. Herbindole A: Bartoli indole synthesis. 
Starting this time with commercially available 3,4-dimethylaniline 43.5, a highly 
regioselective nitration procedure as described above gave the desired compound 46.1 in 
70% yield, with the remaining material consisting mainly of the other easily separated 
nitroaniline isomer. Diazotization and bromination as before gave the o-dibromide 46.2 in 
79% yield. Gratifyingly, the Bartoli protocol afforded the desired indole 43.4 albeit in a 
modest 36% yield. Although this example gave a lower yield than with trikentrin A (36% vs 
52%), we ascribe this observation to the greater substitution of the nitrobenzene. Although 
generalizations are not possible with the Bartoli chemistry it is known that this process is 
highly sensitive to substitution patterns and substituent effects. Accordingly, yields with 
various substitution patterns as reported by that investigator occur over a wide range, and in 
most cases are well below 40%. Electron donating groups (i.e., alkyl) appear to exacerbate 
this effect. The remaining steps have mostly comparable yields to the trikentrin A effort. 
 Although attempts to improve the yield by modifying the reaction conditions proved 
48 
ineffective, it is important to note that there is only one other report in the literature of 
polysubstituted nitrobenzenes participating in this reaction, with much lower yields.
87
 The 
presence of the bromine substitutents in our case appears to attenuate the apparently adverse 
electronic effects due to the remaining meta and para methyl substituents. N-silylation as 
shown above gave the desired TBS-protected 6,7-indolyne precursor 46.3 in 91% yield. 
With the desired aryne precursor in hand, generation of the 6,7-indolyne followed by the 
Diels-Alder reaction gave the cycloadduct 47.1 in an even higher 88% yield than observed 
with trikentrin (Scheme 47). Compound 47.1 was carried through to the target as described 
above. Thus oxidative cleavage (43%, two steps), thioacetalization (81%), and Raney nickel 
reduction (96%) afforded racemic herbindole A in nine steps from the aniline 43.5. 
Herbindole A also exhibited the same physical and spectroscopic data (except for optical 
rotation) as that reported for the authentic samples.  
 
Scheme 47. Herbindole A: 6,7-indolyne tactic. 
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4.4 Attempted Synthesis of (±)-Herbindole B 
Finally, we observed in the case of herbindole B that increasing the electron density of 
the aromatic ring still further results in an even lower yield of the Bartoli indole product 
(Scheme 48). 
 
Scheme 48. Attempt for herbindole B synthesis. 
As noted above multiple electron-donating groups appear to exacerbate this effect to an even 
greater extent. It has been observed by Blechert that the application of the Bartoli protocol to 
highly substituted alkyl nitrobenzenes gives very low yields of the desired indole system and 
thus appears to represent a limitation of the use of this methodology.
87
 However, by carrying 
48.4 through an alternate Fischer indole regime (Scheme 49), the overall yield of the desired 
indole 43.7 is improved to 60% for the four synthetic operations.  
 
Scheme 49. Fischer indole synthesis. 
50 
4.5 Second-Generation Synthesis of (±)-cis-Trikentrin A and Applications to Library 
Development 
During the course of our investigations toward the total synthesis of (±)-cis-trikentrin A, 
the 1,2,5-tribromo-3-nitrobenzene 50.2 was incidentally found in a one pot reaction with 
good yield (Scheme 50). It occurred to us that it might be possible in this system to generate 
selectively the 6,7-indole aryne via metal-halogen exchange while leaving the 4-bromo 
position intact. That position in turn could be used to effect a Negishi cross-coupling reaction 
to install the required ethyl group thereby providing an alternate and shorter route to the 
trikentrins. More generally, this approach could be used with other metal-catalyzed 
cross-coupling reactions (e.g., Suzuki-Miyaura and Buchwald-Hartwig) to create a library of 
trikentrin analogues that would be subjected to biological evaluation. 
 
Scheme 50. Tribromonitrobenzene formation. 
As a test of these strategies, the tribromonitrobenzene 50.2 was converted to the 
4,6,7-tribromoindole (Scheme 51). Thus, 50.2 was first reduced to the tribromonoaniline 51.1 
(EtOH, SnCl2 dihydrate, 5 eq, 70 °C, 82%) followed by conversion to the hydrazine 51.2 (10 
eq ethereal HCl; 1.1 eq NaNO2, 6 N HCl; SnCl2 dihydrate, 3 eq, conc. HCl, 0 °C; 73% for 
three steps). Application of the Fischer-indole synthesis to 51.2 (protonation with ethereal 
51 
HCl; PhCH2CHO, 2 eq, refluxing EtOH, 2 h) gave the desired indole, but in only 31% yield.  
Finally, the indole nitrogen was protected as its N-methyl group (86%).   
 
Scheme 51. Regioselective Li-Bromo exchange and indolyne formation. 
We were delighted to find that the 4,6,7-tribromo-1-methyl-3-phenyl-1H-indole 51.4 reacted 
with n-BuLi and furan to generate cycloadduct 51.5, and without any apparent evidence of 
metal-halogen exchange at C4. Compound 51.5 was not stable to the reaction conditions, and 
was readily attacked by excess n-BuLi, and after aromatization by the addition of a trace of 
acid, produced the ring opened products 51.6a and 51.6b in a 1:1 ratio in a combined 90% 
yield. From these data, we can see that the 6,7-indolyne can be generated exclusively with 
the 4-bromo position untouched. This is a previously unknown phenomenon in these systems. 
 A more gratifying result was observed when we subjected 51.7 to our indolyne-forming 
52 
conditions with only 1.1 eq n-BuLi. The corresponding cycloadduct 51.8 was cleanly formed 
and isolated in 89% yield, again with no evidence of additional metal–halogen exchange 
occurring at C-4. Indeed, efforts to force metal–halogen exchange at the 4-bromoindole 
position with an excess of t-BuLi gave only the ring-opened product 51.9 in excellent yield 
via regio and exoselective attack by the alkyllithium.  
Application of this chemistry led to a second-generation synthesis to trikentrin A, and 
offers a highly flexible approach to potential trikentrin libraries.
69
 Thus inexpensive 
o-nitroaniline 50.1 was brominated [Br2 (4 eq), CH2Cl2/MeOH (2:1), rt, 1 h] in nearly 
quantitative yield to give 4,6-dibromo-2-nitroaniline 52.1. Subsequent diazotization of this 
aniline with a stoichiometric amount of cupric bromide [CuBr2 (1.3 eq), t-BuONO (1.0 eq), 
MeCN, 60 ºC, 1 h] afforded the 2,3,5-tribromonitrobenzene 50.2 in 90% yield consistently 
on a multi-gram (5-10 g) scale. 
 
Scheme 52. Synthesis of the 4,6,7-tribromoindole scaffold. 
Application of the Bartoli indole synthesis to 50.2 (vinyl Grignard, 6 eq; THF, -40 ºC, 20 
min) on a 5-gram scale gave cleanly a very respectable 50% yield of the desired 
53 
4,6,7-tribromoindole 52.2. Finally, protection of the indole N–H group as its TBS ether 52.3 
was accomplished in 78% yield with NaH (4.0 eq), TBSOTf (2.0 eq), and Et3N (2.0 eq) in 
DMF at 0 ºC for 0.5 h. 
As noted earlier, reaction of 52.3 with n-BuLi in PhMe at -78 ºC presumably resulted in 
selective metal–halogen exchange at C-7 and elimination to give the 4-bromo-6,7-indolyne 
53.1, which was trapped with cyclopentadiene to afford the desired 4-bromoindole 53.2 in 
89% yield.  
 
Scheme 53. Tandem 6,7-indolyne cycloaddition/Negishi cross-coupling. 
Although the possibility of some metal–halogen exchange occurring at the 4-bromo position 
cannot be rigorously excluded at this time, it is important to note that no evidence for the 
formation of compound 53.3 has been found thus far. Application of the Negishi 
cross-coupling [Et2Zn, 2.2 eq; Pd2(dba)3 (4 mol %); P(t-Bu)3·HBF4 (16 mol %); THF, 60 ºC, 
1 h] afforded the desired product 46.1 in 70% yield. The use of the somewhat more exotic Fu 
catalyst/ligand combination
134-136
 was found to be the best conditions in this case to achieve 
the optimal yield of the 4-ethylindole. This intermediate is identical in all respects to that 
54 
synthesized by our first-generation method beginning with 4-ethylaniline, and thus 
constitutes a formal total synthesis of (±)-cis-trikentrin A, as well as the shortest route to this 
target reported to date. 
The ability to exploit this reaction orthogonality in the 4,6,7-tribromoindole system makes it 
a potentially valuable scaffold for the construction of trikentrin libraries using a general 
tandem 6,7-indolyne cycloaddition/cross-coupling strategy as depicted in Scheme 54. 
 
Scheme 54. Cross-coupling manifolds in the 4-bromoindole scaffold. 
Thus it should be possible to effect a tandem cycloaddition/cross-coupling sequence with 
a variety of dienes and electrophiles for the subsequent transition metal-catalyzed 
cross-coupling reactions.  The range of useful reactions include the Negishi as noted above, 
Suzuki-Miyaura (with boronic acids), Stille (vinyl tin), Heck (vinyl), Buchwald-Hartwig 
(amines), and Sonogashira (terminal alkynes). If either I or OTf is substituted for Br, then the 
55 
Nozaki-Hiyama-Kishi (NHK) reaction (aldehydes) becomes an additional possibility. We 
have already provided a proof-of-concept for two other manifolds in addition to the Negishi 
reaction. For example, coupling a boronic acid to 53.2 in the Suzuki–Miyaura reaction gave a 
good yield of the desired product 55.1 (Scheme 55), while the use of an aniline afforded the 
corresponding Buchwald–Hartwig coupled product 56.1, albeit in modest yield (Scheme 56). 
 
Scheme 55. Suzuki–Miyaura coupling with 4-bromoindoles. 
 
Scheme 56. Buchwald–Hartwig coupling of anilines with 4-bromoindoles. 
In both cases, the cross-coupling event proceeded with concomitant loss the N-silyl 
protecting group. This unexpected outcome is advantageous in that it saves a deprotection 
step, and allows for the subsequent introduction of further diversity elements, for example, 
by way of N-alkylation or N-acylation. The yields of each reaction deserve comment. While 
the yield of product for the Negishi reaction is certainly respectable, the first attempts at the 
Suzuki–Miyaura and Buchwald–Hartwig cases gave disappointing results. Both are much 
56 
lower than would be expected for simple cross-coupling reactions with an aryl bromide. This 
observation required us, after much experimentation, to finally adopt the less conventional 
catalyst and ligand combinations to achieve even the stated yields. Although cross-coupling 
reactions with haloindoles are certainly precedented,
137
 their yields, along with other 
heteroarenes, tend to be highly variable, and usually low.
138
 In our systems, annulation leads 
to a more electron-rich bromoarene, and this factor is also known to suppress yields in many 
cases. 
The reaction conditions for the Suzuki-Miyaura and Buchwald-Hartwig reactions have 
since been improved. The same catalyst is employed in each case, but the use of new ligand 
and base combinations gave superior yields in both cross-coupling manifolds.  This 
development recently led to the production of a 93-member annulated indole library based on 
this methodology.
139
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CHAPTER 5. CONCLUSIONS 
 In conclusion, we discovered a new class of aryne based on the ubiquitous indole 
nucleus. The unique properties and reaction profiles of the indole arynes (aka indolynes), and 
of the 6,7-indole aryne in particular, have been used to great advantage in both natural 
products total synthesis and natural products-inspired library development, among other 
things. This work has resulted in several important “firsts” for the field of organic chemistry. 
We provided the first evidence for the existence of all three isomeric indole arynes in the 
benzenoid core using a practical and general method for their synthesis via metal-halogen 
exchange with n-BuLi in the corresponding o-dibromides, followed by elimination. The 
facile generation of aryne indoles from o-dibromoindoles is noteworthy for its synthetic 
simplicity and high yields. We found that the 5,6- and 6,7-indole arynes can also be easily 
and selectively generated from the same 5,6-difluoroindole depending on the solvent and 
choice of base. These discoveries alone suggest that indoles can now be considered important 
and versatile members of the suite of aromatic systems from which arynes can be easily 
generated.  
 We provided the first examples of the completely regio- and exoselective ring 
opening of the furan cycloadducts from 6,7-indolynes with alkyllithium reagents. We also 
provided the first experimental evidence that the 6,7-indole aryne, but not the 4,5- and 
5,6-indolynes, undergoes highly regioselective, contrasteric Diels-Alder cycloaddition 
reactions with 2-substituted furans. We found that the 6,7-indolyne/furan cycloadducts can 
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be induced to undergo various rearrangement reactions to afford several additionally useful 
compounds such as annulated enones, indolobenzoquinones, and benzannulated phenols. We 
also demonstrated that 6,7-indole arynes react with allylic acyclic dienes to give predictably 
either predominantly ene products, or regioselective contrasteric  Diels-Alder products, 
depending on the position of the allylic substituent.    
 We conducted in collaboration with the University of Minnesota the first theoretical 
and computational study of the indole arynes which revealed that the 6,7-indolyne in 
particular is a highly polarized system that reacts in a concerted manner but with 
substantially electrophilic substitution character.   
 We provided the first natural products total synthesis application of the indole arynes 
by completing concise total syntheses of the deceptively simple, biologically important 
indole alkaloids (±)-cis-trikentrin A, and (±)-herbindole A and B. This work demonstrated 
the power and synthetic utility of the indole aryne cyloaddition reaction to readily access 
annulated indole natural products. This approach combined with the Bartoli indole synthesis 
provides for an especially efficient synthesis of the trikentrins and herbindoles.  
 Finally, we were the first to demonstrate a useful and practical reaction orthogonality 
regime in arynes derived from tribromoindoles. In this manner we established that 6,7-indole 
arynes can be generated selectively from 4,6,7-tribromoindoles, followed by cycloaddition, 
leaving the unreacted 4-bromo position available for subsequent reactions such as 
cross-coupling. This work led to a shorter and more efficient second-generation synthesis of 
cis-trikentrin A. More significantly, it opened the door for the design and synthesis of natural 
59 
product-like libraries using this strategy. This heretofore unrecognized reaction orthogonality 
renders the 4,6,7-tribromoindole a versatile platform for the total synthesis of natural 
products, and holds enormous potential for the construction of diverse small-molecule 
libraries for use in drug discovery.  
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CHAPTER 6. EXPERIMENTAL SECTION 
6.1 General Details 
1
H NMR (400 MHz) and 
13
C NMR (100 MHz) spectra were recorded with a Varian 
Nova-400 spectrometer, with the samples in CDCl3 unless otherwise noted, with reference to 
residual solvent at  7.24 ppm and 77.0 ppm, respectively.  
Melting Points reported are uncorrected. 
Unless otherwise noted, all commercially obtained starting materials were used as 
received.  Dichloromethane and toluene were distilled from calcium hydride under nitrogen 
prior to use. THF and diethyl ether were distilled from sodium benzophenone ketyl under 
nitrogen prior to use.  
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6.2 Experiment Procedures 
 
(±)-cis-trikentrin A (16.1): In a 100 mL round-bottom flask was added a solution of 88 
mg (0.19 mmol) of (±)-6,8-bis(bis(ethylthio)methyl)-4-ethyl-1,6,7,8-tetrahydrocyclopenta- 
[g]indole 45.4 in 40 mL ethanol. To the stirring solution was added 2 g of Raney-Nickel 
(2800, Aldrich). The resulting suspension was heated to reflux and monitored by TLC. After 
20 min, TLC analysis showed complete conversion and the mixture was cooled to room 
temperature and filtered through a pad of celite. The residue was washed with methanol (3 x 
30 mL) and diethyl ether (1 x 50 mL). The combined filtrate was concentrated under reduced 
pressure, and the crude material was purified by passing through a plug of silica gel and 
eluting with 40% ethyl acetate in hexanes to give 35 mg (85%) of the title compound as a 
slowly darkening oil.  
1
H-NMR and 
13
C-NMR match those reported in the literature.  
HRMS (EI) m/e calcd for C15H19N 213.1519, found 213.1518. 
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(±)-Herbindole A (16.6): See (±)-cis-trikentrin A (16.1). 
1
H NMR (400 MHz, CDCl3) δ 7.91 (bs, 1H), 7.13-7.11 (m, 1H), 6.55-6.54 (m, 1H), 
3.48-3.38 (m, 2H), 2.73-2.62 (m, 2H), 2.46 (s, 3H), 2.32 (s, 3H), 1.44 (d, J= 7.2 Hz, 3H), 
1.34 (d, J = 7.2 Hz, 3H).  
13
C NMR (100 MHz, CDCl3) δ 142.0, 130.4, 127.7, 126.6, 126.4, 123.2, 122.8, 101.6, 
41.8, 39.1, 37.1, 23.8, 22.8, 15.5, 15.3.   
HRMS (EI) m/e calcd for C15H19N 213.1519, found 213.1519. 
Mp = 88-91 °C.  
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3,4-Dichlorophenylhydrazine (18.2): In a 50 mL round-bottom flask was added 1 g 
(6.16 mmol) of 3,4-dicholoroaniline. This was dissolved in 15 mL of methanol with stirring. 
To the stirring solution was carefully added 8 mL (12 N, 96 mmol) of concentrated 
hydrochloric acid. The solution was then evaporated under reduced pressure to give a white 
powder. To the white powder was added dropwise a solution of 460 mg (6.66 mmol, 1.1 eq) 
NaNO2 in 4 mL water at 0 
o
C. The solution was stirred for 20 min at this temperature, and 
then a solution of 4.3 g (19.02 mmol, 3 eq) stannous chloride dihydrate in 10 mL 
concentrated hydrochloric acid was added dropwise. The resulting mixture was left to stand 
in the refrigerator (ca. 4
 o
C) for 6 h, after which time the white precipitate was filtered and 
washed with three 50 mL portions of 20% ether in hexanes. The solid was added to 200 mL 
of 10% aqueous NaOH and 133 mL ether. The biphasic mixture was stirred for 1 h after 
which time the phases were separated and the aqueous layer washed with another two 50 mL 
portions of ether. The combined organic layers were dried over sodium sulfate, filtered and 
concentrated under reduced pressure to give 842 mg (77%) of the title compound as a yellow 
solid.  
1
H NMR (400 MHz, CDCl3) δ 7.36-7.11 (m, 1H), 6.93 (s, 1H), 6.61 (d, J = 7.2 Hz, 1H), 
5.21(bs, 1H), 3.55 (bs, 2H). 
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4,5-Dichloro-3-phenyl-1H-indole (18.3): In a 50 mL round-bottom flask under nitrogen 
was added 50 mg (0.28 mmol) of 3,4-dichlorophenylhydrazine. This was dissolved in 5 mL 
dry THF. To the stirring solution was added 31 μL (0.28 mmol, 1 eq) of phenylacetaldehyde 
and 1 g polyphosphoric acid. The mixture was heated to reflux under nitrogen atmosphere for 
2 h, then concentrated under reduced pressure and immediately separated via column 
chromatography on silica gel using 15% ethyl acetate/hexanes as the eluent to give 30.1 mg 
(40%) of the title compound as a yellow solid and 30.1 mg (40%) of 
5,6-dichloro-3-phenyl-1H-indole as well. 
1
H NMR (400 MHz, CDCl3) δ 8.32 (bs, 1H), 7.50-7.43 (m, 2H), 7.41-7.31 (m, 3H), 
7.30-7.25 (m, 2H), 7.18 (d, J = 2.5 Hz, 1H). 
 5,6-Dichloro-3-phenyl-1H-indole (18.4):  
1
H NMR (400 MHz, CDCl3) δ 8.10 (bs, 1H), 7.84 (s, 1H), 7.45 (apparent d, J = 7.2 Hz, 
2H), 7.39 (s, 1H), 7.32 (apparent t, J = 7.7 Hz, 2H), 7.21-7.15 (m, 1H), 7.12 (s, 1H). 
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4,5-Dichloro-1-methyl-3-phenyl-1H-indole (18.5): In a 25 mL flame-dried 
round-bottom flask under nitrogen was added 135 mg (0.51 mmol) of 
4,5-dichloro-3-phenyl-1H-indole. This was dissolved in 2 mL dry THF and to the solution 
was added 14.7 mg (0.61 mmol, 1.2 eq) of dry sodium hydride. The solution was stirred at 
room temperature for 30 min, and then 63 μL (1.02 mmol, 2.0 eq) of iodomethane was added 
via syringe. The resulting solution was stirred for 2 h and refluxed for another 30 min, and 
then quenched by dropwise addition of 10 mL water. The aqueous mixture was extracted 
with three portions of 25 mL diethyl ether. The combined organic layers were washed with 
brine (10 mL), dried over magnesium sulfate, filtered and concentrated under reduced 
pressure. The residue was then purified via column chromatography on silica gel using 20% 
ethyl acetate/hexanes as eluent to give 126 mg (90%) of the title compound as a yellow oil. 
1
H NMR (400 MHz, CDCl3) δ 7.48-7.42 (m, 2H), 7.40-7.28 (m, 4H), 7.18 (d, J = 8.7 Hz, 
1H), 7.04 (s, 1H), 3.80 (s, 3H). 
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5,6-Dichloro-1-methyl-3-phenyl-1H-indole (18.6): In a 25 mL flame-dried 
round-bottom flask under nitrogen was added 65.2 mg (0.25 mmol) of 
5,6-dichloro-3-phenyl-1H-indole. This was dissolved in 2 mL dry THF and to the solution 
was added 7.2 mg (0.3 mmol, 1.2 eq) of dry sodium hydride. The solution was stirred at 
room temperature for 30 min, then 31 μL (0.5 mmol, 2.0 eq) of iodomethane was added via 
syringe. The resulting solution was stirred for 2 h, and then quenched by dropwise addition 
of 10 mL water. The aqueous mixture was extracted with three portions of 25 mL diethyl 
ether. The combined organic layers were washed with brine (10 mL), dried over magnesium 
sulfate, filtered and concentrated under reduced pressure. The residue was then purified via 
column chromatography on silica gel using 20% ethyl acetate/hexanes as eluent to give 65.8 
mg (95%) of the title compound as a yellow solid. 
1
H NMR (400 MHz, CDCl3) δ 7.95 (s, 1H), 7.58-7.52 (m, 2H), 7.45-7.40 (m, 3H), 7.32 
-7.25 (m, 1H), 7.21 (s, 1H), 3.78 (s, 3H). 
 
13
C NMR (100 MHz, CDCl3) δ 136.40, 134.56, 129.09, 128.32, 127.33, 126.43, 125.88, 
125.86, 124.10, 121.01, 116.62, 111.20, 33.24. 
 
 
 
67 
 
 3-methyl-1-phenyl-6,9-dihydro-3H-6,9-epoxybenzo[e]indole (19.2):  
See 1-methyl-3-phenyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (22.2) 
 
1
H NMR (400 MHz, CD3CN) δ 7.46-7.51 (m, 4 H), 7.24-7.34 (m, 4 H), 7.18 (dd, J = 1.6 
Hz and 5.6 Hz, 1 H), 7.00 (d, J =8.0 Hz, 1 H), 5.87 (bs, 1 H), 5.76 (s, 1 H), 3.77 (s, 3 H) 
HRMS (EI) m/e calcd for C19H15NO 273.1154, found 273.1159. 
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 1-methyl-3-phenyl-5,8-dihydro-1H-5,8-epoxybenzo[f]indole (19.4):  
See 1-methyl-3-phenyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (22.2). 
 
1
H NMR (400 MHz, CD3CN) δ 7.72(s, 1H), 7.61 (d, J = 7.6 Hz, 2 H), 7.42 (t, J = 8.0 Hz, 
2 H), 7.34 (m, 2 H), 7.24 (apparent t, J = 7.6 Hz, 1 H), 7.01 (s, 2 H), 5.73 (s, 1 H), 5.70 (s, 1 
H), 3.78 (s, 3 H) 
HRMS (EI) m/e calcd for C19H15NO 273.1154, found 273.1157. 
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5-bromo-4-fluoro-3-phenyl-1H-indole (20.1a):  
See 5,6-Dichloro-3-phenyl-1H-indole (18.4). 
1
H NMR (400 MHz, CDCl3) δ 8.42 (bs, 1H), 7.62-7.56 (m, 2H), 7.47-7.21 (m, 5H), 7.10 
(dd, J = 8.6, 3.4 Hz, 1H). 
5-bromo-6-fluoro-3-phenyl-1H-indole (20.2a):  
1
H NMR (400 MHz, CDCl3) δ 8.26 (bs, 1H), 8.03 (d, J = 6.7 Hz, 1H), 7.62-7.54 (m, 
2H), 7.49-7.40 (m, 2H), 7.37-7.27 (m, 2H), 7.19 (dd, J = 8.9, 0.8 Hz, 1H). 
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6-chloro-5-iodo-3-phenyl-1H-indole (20.3a): See 5,6-Dichloro-3-phenyl-1H-indole 
(18.4). 
1
H NMR (400 MHz, CDCl3) δ 8.36 (bs, 1H), 7.64 (d, J = 8.6 Hz, 1H), 7.48-7.41 (m, 
2H), 7.40-7.32 (m, 3H), 7.14 (s, 1H), 7.09 (d, J = 8.6 Hz, 1H). 
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6,7-dichloro-3-phenyl-1H-indole (20.4a): See 5,6-Dichloro-3-phenyl-1H-indole (18.4). 
 
1
H NMR (400 MHz, CDCl3) δ 8.48 (bs, 1H), 7.72 (d, J = 8.6 Hz, 1H), 7.62-7.57 (m, 
2H), 7.48-7.42 (m, 2H), 7.38 (s, 1H), 7.32 (t, J = 7.4 Hz, 1H), 7.23 (d, J = 8.6 Hz, 1H) 
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4,5-dibromo-3-phenyl-1H-indole (20.5a): See 5,6-Dichloro-3-phenyl-1H-indole (18.4). 
The starting material (3,4-dibromophenyl)hydrazine was made from 3,4-dibromoaniline
140
 as 
the same procedure as 3,4-Dichlorophenylhydrazine (18.2). 
1
H NMR (400 MHz, CDCl3) δ 8.46 (bs, 1H), 7.34-7.30 (m, 3H), 7.26-7.22 (m, 3H), 7.08 
(d, J = 8.6 Hz, 1H), 7.01 (d, J = 2.5 Hz, 1H). 
5,6-dibromo-3-phenyl-1H-indole (20.6a):  
 
1
H NMR (400 MHz, CDCl3) δ 8.25 (bs, 1H), 8.07 (s, 1H), 7.60 (s, 1H), 7.53-7.47 (m, 
2H), 7.42-7.35 (m, 2H), 7.28-7.21 (m, 2H).  
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6,7-dibromo-3-phenyl-1H-indole (20.7a):  
The starting material 1,2-dibromophenylhydrazine was made from 1,2-dibromoaniline
140
 
using the same procedure as 3,4-Dichlorophenylhydrazine (18.2).  
Dissolved 1.09 g (4.10 mmol) 1,2-dibromophenylhydrazin in a small amount of Et2O, 
then added 2.05 mL 2 M HCl (1 eq) into the solution dropwise. Filtered the mixture and got 
white salts, washed the salts with Et2O thoroughly, then dried it under vacuum. Then in a 100 
mL round-bottom flask was added the dried salts, 478 µL phenylacetaldehyde (1 eq ), and 30 
mL EtOH, this was refluxed under N2 atmosphere for 3 hours, then quenched with NaHCO3 
saturated solution and extracted with Et2O. The organic layer was dried over magnesium 
sulfate, filtered and concentrated under reduced pressure. The residue was then purified via 
column chromatography on silica gel using 20% ethyl acetate/hexanes as eluent to give 963.3 
mg (67%) of the title compound. 
1
H NMR (400 MHz, CDCl3) δ 8.45 (bs, 1H), 7.70 (dd, J = 8.5, 0.7 Hz, 1H), 7.61-7.56 
(m, 2H), 7.47-7.41 (m, 2H), 7.38 (dd, J = 5.5, 3.0 Hz, 2H), 7.34-7.28 (m, 1H).  
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4,5-difluoro-3-phenyl-1H-indole (20.8a): See 5,6-Dichloro-3-phenyl-1H-indole (18.4). 
1
H NMR (400 MHz, CDCl3) δ 8.35 (bs, 1H), 7.62-7.57 (m, 2H), 7.44-7.38 (m, 2H), 7.33 
-7.28 (m, 1H), 7.25 (d, J = 2.5 Hz, 1H), 7.07-7.04 (m, 2H). 
5,6-difluoro-3-phenyl-1H-indole (20.9a):  
1
H NMR (400 MHz, CDCl3) δ 8.27 (bs, 1H), 7.63 (dd, J = 11.1, 7.8 Hz, 1H), 7.60-7.55 
(m, 2H), 7.47-7.42 (m, 2H), 7.35 (d, J = 2.5 Hz, 1H), 7.33-7.27 (m, 1H), 7.18 (dd, J = 10.4, 
6.7 Hz, 1H).  
 
 
 
 
 
 
 
 
75 
 
6,7-difluoro-3-phenyl-1H-indole (20.10a): See 5,6-Dichloro-3-phenyl-1H-indole 
(18.4). 
1
H NMR (400 MHz, CDCl3) δ 8.55 (s, 1H), 7.61-7.05 (m, 8H).  
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5-bromo-4-fluoro-1-methyl-3-phenyl-1H-indole (20.1b): See 4,5-Dichloro-1-methyl- 
3-phenyl-1H-indole (18.5). 
1
H NMR (400 MHz, CDCl3) δ 7.58-7.53 (m, 2H), 7.38 (t, J = 7.8 Hz, 2H), 7.32 (dd, J = 
8.7, 6.2 Hz, 1H), 7.30-7.25 (m, 1H), 7.08 (s, 1H), 7.00 (d, J = 8.7 Hz, 1H), 3.80 (s, 3H).  
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5-bromo-6-fluoro-1-methyl-3-phenyl-1H-indole (20.2b):   
See 4,5-Dichloro-1-methyl-3-phenyl-1H-indole (18.5). 
1
H NMR (400 MHz, CDCl3) δ 8.02 (d, J = 6.7 Hz, 1H), 7.58-7.53 (m, 2H), 7.46-7.40 (m, 
2H), 7.32-7.25 (m, 1H), 7.18 (s, 1H), 7.09 (d, J = 9.2 Hz, 1H), 3.76 (s, 3H). 
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6-chloro-5-iodo-1-methyl-3-phenyl-1H-indole (20.3b):  
See 4,5-Dichloro-1-methyl-3-phenyl-1H-indole (18.5). 
1
H NMR (400 MHz, CDCl3) δ 8.34 (s, 1H), 7.57-7.52 (m, 2H), 7.48 (s, 1H), 7.46-7.40 
(m, 2H), 7.31-7.26 (m, 1H), 7.17 (s, 1H), 3.77 (s, 3H). 
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6,7-dichloro-1-methyl-3-phenyl-1H-indole (20.4b):  
See 5,6-Dichloro-1-methyl-3-phenyl-1H-indole (18.6). 
1
H NMR (400 MHz, CDCl3) δ 7.66 (dd, J = 8.6, 0.6 Hz, 1H), 7.56-7.51 (m, 2H), 7.46- 
7.39 (m, 2H), 7.32-7.26 (m, 1H), 7.19 (dd, J = 8.6, 0.6 Hz, 1H), 7.11 (s, 1H), 4.18 (s, 3H). 
13
C NMR (100 MHz, CDCl3) δ 134.42, 129.96, 128.95, 128.71, 128.57, 127.63, 127.03, 
126.42, 121.98, 118.88, 116.91, 115.74, 37.28.  
 HRMS (EI) m/e calcd for C15H11Cl2N 275.0270, found 275.0271.  
Mp = 104-105 °C. 
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4,5-dibromo-1-methyl-3-phenyl-1H-indole (20.5b):  
See 5,6-Dichloro-1-methyl-3-phenyl-1H-indole (18.6). 
1
H NMR (400 MHz, CDCl3) δ 7.41-7.47 (m, 3 H), 7.34-7.36 (m, 3 H), 7.18 (d, J = 8.8 
Hz, 1 H), 7.03 (s, 1 H), 3.79 (s, 3 H). 
HRMS (EI) m/e calcd for C15H11Br2N 362.9258, found 362.9260. 
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5,6-dibromo-1-methyl-3-phenyl-1H-indole (20.6b):  
See 5,6-Dichloro-1-methyl-3-phenyl-1H-indole (18.6). 
1
H NMR (400 MHz, CDCl3) δ 8.12 (s, 1 H), 7.60 (s, 1 H), 7.53 (d, J = 7.6 Hz, 2 H), 7.28 
(apparent t, J = 7.6 Hz, 1 H), 7.24 (apparent t, J = 7.6 Hz, 2 H), 3.75 (s, 3 H), 7.16 (s, 1 H).  
HRMS (EI) m/e calcd for C15H11Br2N 362.9258, found 362.9261.  
Mp = 112-113 °C. 
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6,7-dibromo-1-methyl-3-phenyl-1H-indole (20.7b):  
See 5, 6-Dichloro-1-methyl-3-phenyl-1H-indole (18.6). 
1
H NMR (400 MHz, CDCl3) δ 7.64 (d, J = 8.5 Hz, 1H), 7.55-7.50 (m, 2H), 7.46-7.40 (m, 
2H), 7.36 (d, J = 8.5 Hz, 1H), 7.33-7.27 (m, 1H), 7.10 (s, 1H), 4.18 (s, 3H).  
HRMS (EI) m/e calcd for C15H11Br2N 362.9258, found 362.9259.  
Mp = 101-102 °C. 
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4,5-difluoro-1-methyl-3-phenyl-1H-indole (20.8b):  
See 5,6-Dichloro-1-methyl-3-phenyl-1H-indole (18.6) 
1
H NMR (400 MHz, CDCl3) δ 7.62-7.55 (m, 2H), 7.43-7.37 (m, 2H), 7.31-7.25 (m, 1H), 
7.12 (s, 1H), 7.07 (ddd, J = 10.5, 8.9, 7.1 Hz, 1H), 6.99 (ddd, J = 8.9, 3.5, 1.0 Hz, 1H), 3.79 
(s, 3H). 
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5,6-difluoro-1-methyl-3-phenyl-1H-indole (20.9b):  
See 5,6-Dichloro-1-methyl-3-phenyl-1H-indole (18.6). 
1
H NMR (400 MHz, CDCl3) δ 7.67 (dd, J = 11.2, 7.8 Hz, 1H), 7.62-7.55 (m, 2H), 7.53- 
7.42 (m, 2H), 7.36-7.29 (m, 1H), 7.21 (s, 1H), 7.10 (dd, J = 10.6, 6.7 Hz, 1H), 3.74 (s, 3H).  
13
C NMR (100 MHz, CDCl3) δ 149.36, 149.20, 148.16, 148.01, 146.96, 146.80, 145.80, 
145.65, 134.96, 132.91, 132.81, 129.07, 127.76, 127.72, 127.19, 126.27, 121.41, 121.33, 
117.00, 116.95, 106.77, 106.58, 97.75, 97.53, 33.29.  
19
F NMR (376 MHz, CDCl3) δ -143.43--143.82 (m, 1F), -147.69--148.10 (m, 1F). 
 HRMS (EI) m/e calcd for C15H11F2N 243.0860, found 243.0861.  
Mp = 111-112 °C. 
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6,7-difluoro-1-methyl-3-phenyl-1H-indole (20.10b):  
See 5,6-Dichloro-1-methyl-3-phenyl-1H-indole (18.6). 
1
H NMR (400 MHz, CDCl3) δ 7.58-7.54 (m, 2H), 7.50 (ddd, J = 8.8, 4.3, 1.2 Hz, 1H), 
7.45-7.39 (m, 2H), 7.32-7.25 (m, 1H), 7.11 (s, 1H), 7.00-6.90 (m, 1H), 4.01 (d, J = 1.8 Hz, 
3H). 
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4-fluoro-1-methyl-3-phenyl-1H-indole (21.2):  
See 6-fluoro-1-methyl-3-phenyl-1H-indole (21.4). 
1
H NMR (400 MHz, CDCl3) δ 7.63-7.56 (m, 2H), 7.43-7.35 (m, 2H), 7.29-7.24 (m, 1H), 
7.16 (dd, J = 7.5, 4.7 Hz, 1H), 7.13-7.09 (m, 2H), 6.82 (ddd, J = 11.6, 7.5, 1.1 Hz, 1H), 3.82 
(s, 3H). 
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6-fluoro-1-methyl-3-phenyl-1H-indole (21.4):  
In a flame-dried 5 mL round-bottom flask under nitrogen was added 14 mg (0.046 
mmol) of 5-bromo-6-fluoro-1-methyl-3-phenyl-1H-indole (20.2b) and 47 μL (0.46 mmol, 10 
eq) of furan; these were then dissolved in 2 mL dry diethyl ether and cooled to -78 °C. To the 
cold solution was added dropwise 105 μL (0.15 mmol, 3.3 eq) of a 1.45 M t-butyllithium in 
hexanes solution. The solution was stirred at -78 °C for 30 min. The cold bath was then 
removed and the solution was allowed to slowly warm to room temperature with stirring. 
After 1 h, the reaction was quenched by addition of 5 mL water. The product was extracted 
with 3 x 5 mL diethyl ether, and the combined organic layers were then dried over 
magnesium sulfate, filtered and concentrated under reduced pressure. The residue was 
purified via column chromatography on silica gel using 30% ethyl acetate/hexanes as the 
eluent to give 9.2 mg (89%) of the title compound as a white solid.  
1
H NMR (400 MHz, CDCl3) δ 7.82 (dd, J = 8.7, 5.3 Hz, 1H), 7.64-7.56 (m, 2H), 7.47- 
7.38 (m, 2H), 7.31-7.24 (m, 1H), 7.19 (s, 1H), 7.01 (dd, J = 9.7, 2.2 Hz, 1H), 6.93 (ddd, J = 
9.5, 8.8, 2.3 Hz, 1H), 3.77 (s, 3H). 
13
C NMR (100 MHz, CDCl3) δ 161.36, 158.99, 137.81, 137.69, 135.41, 129.01, 127.49, 
126.91, 126.87, 126.16, 122.92, 121.06, 120.96, 117.20, 108.86, 108.62, 96.21, 95.95, 33.21. 
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6-chloro-1-methyl-3-phenyl-1H-indole (21.6):  
See 6-fluoro-1-methyl-3-phenyl-1H-indole (21.4).  
Starting material 6-chloro-5-iodo-1-methyl-3-phenyl-1H-indole was made from 
3-chloro-4-iodophenylhydrazine (35) as before. 
 
1
H NMR (400 MHz, CDCl3) δ 7.80 (d, J = 8.5 Hz, 1H), 7.62-7.56 (m, 2H), 7.42 
(apparent t, J = 7.8 Hz, 3H), 7.34 (d, J = 1.4 Hz, 1H), 7.30-7.25 (m, 1H), 7.20 (s, 1H), 7.12 
(dd, J = 8.5, 1.8 Hz, 1H), 3.80 (s, 3H). 
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1-methyl-3-phenyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (22.2): In a flame-dried 
5 mL round-bottom flask under nitrogen was added 21 mg (0.059 mmol) of 
6,7-dibromo-1-methyl-3-phenyl-1H-indole and 86 μL (1.2 mmol, 20 eq) of furan; these were 
then dissolved in 2 mL dry diethyl ether and cooled to -78 °C. To the cold solution was 
added dropwise 65 μL (0.065 mmol, 1.1 eq) of a 1.0 M n-butyllithium in hexanes solution. 
The solution was stirred at -78 °C for 30 min. The cold bath was then removed and the 
solution was allowed to slowly warm to room temperature with stirring. After 1 h, the 
reaction was quenched by addition of 5.2 mL water. The product was extracted with 3 x 5 
mL diethyl ether, and the combined organic layers were then dried over magnesium sulfate, 
filtered and concentrated under reduced pressure. The residue was purified via column 
chromatography on silica gel using 20% ethyl acetate/hexanes as the eluent to give 13 mg 
(79%) of the title compound as a white solid.  
1
H NMR (400 MHz, CD3CN) δ 7.63 (d, J = 6.4 Hz, 2 H), 7.51 (d, J = 8.0 Hz, 1 H), 7.42 
(apparent t, J = 7.8 Hz, 2 H), 7.34 (s, 1 H), 7.25 (apparent t, J = 7.6 Hz, 1 H), 7.14-7.21 (m, 3 
H), 6.33 (s, 1 H), 5.82 (s, 1 H), 3.95 (s, 3 H).  
HRMS (EI) m/e calcd for C19H15NO 273.1154, found 273.1155.  
Mp= 158-159 °C. 
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 (±)-8-(tert-butyl)-1-methyl-3-phenyl-8,9-dihydro-1H-benzo[g]indol-9-ol (22.3): See 
5-fluoro-1-methyl-3-phenyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (31.3). 
1
H NMR (400 MHz, CDCl3) δ 7.81 (d, J = 8.0 Hz, 1 H), 7.60 (d, J =7.2 Hz, 2 H), 7.43 
(apparent t, J = 8.0 Hz, 2 H), 7.26 (apparent t, J = 7.2 Hz, 1H), 7.15 (s, 1 H), 6.98 (d, J = 8.0 
Hz, 1 H), 6.76 (dd, J = 3.2 Hz and 10 Hz, 1 H), 6.00 (d, J = 10 Hz, 1 H), 5.59 (d, J = 5.2 Hz, 
1 H), 4.17 (s, 3 H), 2.29 (q, J = 3.2 Hz, 1 H), 1.23 (s, 9 H).  
HRMS (EI) m/e calcd for C19H25NO 283.1937, found 283.1939. 
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 8-(tert-butyl)-1-methyl-3-phenyl-1H-benzo[g]indole (22.4):  
Dissolved 22.3 in chloroform-D, and sat at room temperature for 7 hours. All starting 
material 22.3 was aromatized to product 22.4. 
1
H NMR (400 MHz, CDCl3) δ 8.48 (d, J = 2 Hz, 1 H), 7.90 (apparent t, J = 8.4 Hz, 2 H), 
7.65-7.67 (m, 2 H), 7.50-7.54 (m, 2 H), 7.45 (apparent t, J = 5.2 Hz, 2 H), 7.28 (apparent t, J 
= 7.2 Hz, 1 H), 7.19 (s, 1 H), 4.36 (s, 3 H), 1.46 (s, 9 H).  
13
C NMR (100 MHz, CDCl3) δ 148.1, 135.8, 131.2, 129.6, 129.0, 128.9, 128.1, 127.1, 
126.1, 123.6, 123.5, 122.3, 121.1, 119.2, 118.0, 116.3, 39.0, 35.3, 31.7.  
HRMS (EI) m/e calcd for C19H23N 265.1831, found 265.1832. 
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 (±)-8-(tert-butyl)-1,6,9-trimethyl-3-phenyl-8,9-dihydro-1H-benzo[g]indol-9-ol (25.2): 
See 5-fluoro-1-methyl-3-phenyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (31.3). 
 
1
H NMR (400 MHz, CD3CN) δ 7.70 (d, J = 8.4 Hz, 1 H), 7.65 (d, J = 8.4 Hz, 2 H), 7.44 
(apparent t, J = 7.4 Hz, 2 H), 7.35 (d, J = 8.4 Hz, 1 H), 7.30 (s, 1 H) , 7.28 (t, J = 7.6 Hz, 1H), 
6.03 (dd, J = 1.6 and 8.0 Hz, 1 H), 3.79 (s, 3 H), 2.96 (s, 1 H), 2.20 (s, 3 H), 1.49 (s, 3 H), 
0.86 (s, 9 H) 
HRMS (EI) m/e calcd for C25H29NO 359.2250, found 359.2252. 
(±)-7-(tert-butyl)-1,6,9-trimethyl-3-phenyl-6,7-dihydro-1H-benzo[g]indol-6-ol (25.3):  
1
H NMR (400 MHz, CD3CN) δ 7.72 (d, J = 8.4 Hz, 1 H), 7.62 (d, J = 5.2 Hz, 2 H), 7.44 
(apparent t, J = 8.0 Hz, 2 H), 7.34 (s, 1 H), 7.27 (apparent t, J = 7.6 Hz, 1H), 7.09 (d, J = 8.4 
Hz, 1 H), 2.95 (s, 1 H), 5.84 (dd, J = 1.2 and 6.8 Hz, 1 H), 4.13 (s, 3 H), 2.11 (s, 3 H), 1.75 
(s, 3 H), 0.81 (s, 9 H)  
HRMS (EI) m/e calcd for C25H29NO 359.2250, found 359.2250. 
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 3,6,9-trimethyl-1-phenyl-6,9-dihydro-3H-6,9-epoxybenzo[e]indole (28.1):  
See 1-methyl-3-phenyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (22.2) 
 
1
H NMR (400 MHz, CDCl3) δ 7.44-7.31 (m, 5H), 7.15 (d, J = 8.0 Hz, 1H), 6.98 (d, J = 
3.6 Hz, 1H), 6.94 (dt, J = 9.6, 5.6 Hz, 3H), 3.75 (s, 3H), 1.95 (s, 3H), 1.21 (s, 3H). 
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 1,5,8-trimethyl-3-phenyl-5,8-dihydro-1H-5,8-epoxybenzo[f]indole (28.2):  
See 1-methyl-3-phenyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (22.2), except for 
using 2,5-dimethylfuran instead of furan. 
 
1
H NMR (400 MHz, CD3CN) δ 7.62 (d, J = 8.0 Hz, 2H), 7.57 (s, 1 H), 7.42 (apparent t, J 
= 8.0 Hz, 2 H), 7.33 (s, 1 H), 7.23-7.26 (m, 2 H), 6.78 (s, 2 H), 3.79 (s, 3 H), 1.87 (s, 3 H), 
1.85 (s, 3 H).  
HRMS (EI) m/e calcd for C21H19NO 301.1467, found 301.1462. 
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 3-methyl-1-phenyl-6,9-dihydro-3H-6,9-methanobenzo[e]indole (29.1):  
See 1-methyl-3-phenyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (22.2), except for 
using cyclopentadiene instead of furan. 
 
1
H NMR (400 MHz, CD3CN) δ 7.58-7.50 (m, 2H), 7.50-7.40 (m, 2H), 7.35-7.26 (m, 
1H), 7.24-7.17 (m, 2H), 6.94 (d, J = 7.1 Hz, 3H), 4.17 (s, 1H), 3.96 (s, 1H), 3.74 (s, 3H), 2.24 
(d, J = 6.5 Hz, 1H), 2.13 (d, J = 6.5 Hz, 1H). 
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 1-methyl-3-phenyl-6,9-dihydro-1H-6,9-methanobenzo[g]indole (30.1):  
In a flame-dried 25 mL round-bottom flask was added a solution of 20 mg (0.055 mmol) 
6,7-dibromo-1-methyl-3-phenyl-1H-indole 20.7b in 2 mL dry toluene. To this was added 7.4 
mg (0.11 mmol) of freshly cracked cyclopentadiene. The resulting solution was cooled to 
-78 °C, then 93 µL (0.11 mmol) of a 1.2 M solution of n-butyllithium in hexanes was added 
dropwise via syring over 15 min. The solution was stirred at -78 °C for 30 min then allowed 
to slowly warm to room temperature. The reaction was then quenched by addition of 10 mL 
saturated ammonium chloride. After stirring for 5 min, the mixture was diluted with 10 mL 
water and extracted with 3 x 10 mL dichloromethane. The combined organic phase was dried 
over anhydrous magnesium sulfate, filtered and concentrated under reduced pressure. The 
crude material was then purified via column chromatography on silica gel using 5% 
dichloromethane in hexanes as eluent to give 13.1 mg (88%) of the title compound as a white 
solid. 
 
1
H NMR (400 MHz, CDCl3) δ 7.61-7.57 (m, 2H), 7.50 (d, J = 7.8 Hz, 1H), 7.42-7.36 (m, 
2H), 7.25-7.20 (m, 1H), 7.17 (d, J = 7.8 Hz, 1H), 7.05 (s, 1H), 6.92 (dd, J = 5.3, 3.0 Hz, 1H), 
6.86 (dd, J = 5.2, 3.0 Hz, 1H), 4.54 (s, 1H), 4.03 (s, 1H), 3.99 (s, 3H), 2.46-2.34 (m, 2H). 
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5-fluoro-1-methyl-3-phenyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (31.3): In a 
flame-dried 5 mL round-bottom flask under nitrogen was added 20 mg (0.08 mmol) of 
5,6-difluoro-1-methyl-3-phenyl-1H-indole (20.9b) and 116 μL (1.6 mmol, 20 eq) of furan; 
these were then dissolved in 2 mL dry diethyl ether and cooled to -78 °C. To the cold 
solution was added dropwise 108 μL (0.35 mmol, 4.4 eq) of a 1.7 M t-butyllithium in 
hexanes solution. The solution was stirred at -78 °C for 30 min. The cold bath was then 
removed and the solution was allowed to slowly warm to room temperature with stirring. 
After 1 h, the reaction was quenched by addition of 5 mL water. The product was extracted 
with 3 x 5 mL diethyl ether, and the combined organic layers were then dried over 
magnesium sulfate, filtered and concentrated under reduced pressure. The residue was 
purified via column chromatography on silica gel using 20% ethyl acetate/hexanes as the 
eluent to give 18.6 mg (80%) of the title compound as a white solid.  
1
H NMR (400 MHz, CDCl3) δ 7.53 (d, J= 8.0 Hz, 2 H), 7.40 (apparent t, J = 7.6 Hz, 2 
H), 7.25 (apparent t, J = 7.0 Hz, 1 H), 7.18-7.20 (m, 2 H), 7.11-7.14 (m, 2 H), 6.28 (s, 1 H), 
6.10 (s, 1 H), 3.93 (s, 3 H).  
13
C NMR (100 MHz, CDCl3) δ 154.1, 151.7, 144.5, 143.4, 135.2, 130.8, 130.5, 129.7, 
129.1, 128.1, 127.4, 126.3, 117.3, 102.8, 102.6, 81.7, 80.3, 35.3.  
HRMS (EI) m/e calcd for C19H14FNO 291.1060, found 291.1058. 
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9-(tert-butyl)-1-methyl-3-phenyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (32.2a): 
See 1-methyl-3,9-diphenyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (1-4a). 
1
H NMR (400 MHz, CDCl3) δ 7.56-7.51 (m, 3H), 7.43-7.38 (m, 2H), 7.29-7.24 (m, 1H), 
7.16-7.12 (m, 2H), 7.03 (d, J = 5.5 Hz, 1H), 7.01(s, 1H), 5.17 (d, J = 1.8 Hz, 1H), 3.99 (s, 
3H), 1.45 (s, 9H). 
13
C NMR (100 MHz, C6D6) δ 29.6, 33.7, 39.1, 82.2, 104.6, 114.1, 116.9, 118.5, 126.4, 
128.4, 129.0, 129.7, 131.0, 135.2, 135.6, 136.0, 142.6, 146.4, 149.3.  
HRMS (EI) m/e calcd for C23H23NO 329.1781, found 329.1779. 
6-(tert-butyl)-1-methyl-3-phenyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (32.2b): 
1
H NMR (400 MHz, CDCl3) δ 7.61-7.57 (m, 2H), 7.52 (d, J = 8.1 Hz, 1H), 7.43-7.38 (m, 
2H), 7.36 (d, J = 8.1 Hz, 1H), 7.28-7.23 (m, 1H), 7.12-7.07 (m, 3H), 6.24 (d, J = 1.5 Hz, 1H), 
3.93 (s, 3H), 1.35 (s, 9H).  
13
C NMR (100 MHz, THF-d8) δ 27.13, 30.63, 34.91, 80.79, 100.45, 115.47, 115.52, 
117.32, 126.05, 127.75, 129.15, 129.01, 129.27, 133.61, 136.57, 137.02, 144.72, 145.55, 
145.68.  
HRMS (EI) m/e calcd for C23H23NO 329.1781, found 329.1782. 
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1,9-dimethyl-3-phenyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (1-1a): See 
1-methyl-3,9-diphenyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (1-4a). 
 
1
H NMR (400 MHz, CD3CN) δ 7.62-7.58 (m, 2H), 7.49 (d, J = 7.8 Hz, 1H), 7.44-7.39 
(m, 2H), 7.27 (s, 1H), 7.27-7.22 (m, 1H), 7.15-7.11 (m, 2H), 6.94 (d, J = 5.4 Hz, 1H), 5.68 (d, 
J = 1.9 Hz, 1H), 3.96 (s, 3H), 2.14 (s, 3H).   
13
C NMR (100 MHz, CD3CN) δ 20.76, 38.16, 82.97, 91.72, 113.93, 116.32, 116.73, 
126.59, 128.10, 128.23, 129.59, 130.67, 133.81, 135.59, 136.31, 146.74, 147.21, 148.82.  
HRMS (EI) m/e calcd for C20H17NO 287.1311, found 287.1313. 
1,6-dimethyl-3-phenyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (1-1b): 
1
H NMR (400 MHz, CDCl3) δ 7.61-7.54 (m, 3H), 7.43-7.37 (m, 2H), 7.27-7.22 (m, 1H), 
7.13-7.08 (m, 3 H), 6.90 (d, J = 5.5 Hz, 1H), 6.20 (d, J = 1.8 Hz, 1H), 3.93 (s, 3H), 2.01 (s, 
3H).   
13
C NMR (100 MHz, CD3CN) δ 15.62, 35.15, 81.20, 90.38, 112.93, 116.06, 116.70, 
126.47, 126.61, 127.78, 129.61, 129.80, 133.36, 134.74, 136.49, 145.70, 147.76, 148.01. 
HRMS (EI) m/e calcd for C20H17NO 287.1311, found 287.1312. 
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 9-ethyl-1-methyl-3-phenyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (1-2a): See 
1-methyl-3,9-diphenyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (1-4a). 
 
1
H NMR (400 MHz, C6D6) δ 7.69-7.64 (m, 3H), 7.37-7.31 (m, 2H), 7.21-7.16 (m, 1H), 
7.04 (d, J = 7.9 Hz, 1H), 6.83 (dd, J = 5.5, 1.9 Hz, 1H), 6.55 (s, 1H), 6.52 (d, J = 5.4 Hz, 1H), 
5.56 (d, J = 1.8 Hz, 1H), 3.07 (s, 3H), 2.39-2.32 (m, 2H), 1.20 (t, J = 7.4 Hz, 3H).  
13
C NMR (100 MHz, CD3CN) δ 10.19, 26.60, 37.85, 82.87, 96.40, 114.15, 116.46, 
116.99, 126.74, 128.27, 128.38, 129.72, 131.03, 134.29, 134.71, 136.42, 146.35, 146.96, 
149.30.  
HRMS (EI) m/e calcd for C21H19NO 301.1468, found 301.1467. 
 6-ethyl-1-methyl-3-phenyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (1-2b): 
 
1
H NMR (400 MHz, C6D6) δ 7.73-7.69 (m, 3H), 7.38-7.32 (m, 2H), 7.21-7.16 (m, 1H), 
7.08 (d, J = 7.9 Hz, 1H), 6.77 (dd, J = 5.4 Hz, 1.8 Hz, 1H), 6.69 (d, J = 5.4 Hz 1H), 6.54 (s, 
1H), 5.92 (d, J = 1.8 Hz, 1H), 2.84 (s, 3H), 2.35 (q, J = 7.5 Hz, 2H), 1.28 (t, J = 7.5 Hz, 3H). 
13
C NMR (100 MHz, THF-d8) δ 8.68, 22.40, 34.03, 80.43, 93.53, 109.99, 112.26, 115.20, 
125.30, 126.27, 127.05, 128.21, 128.50, 134.61, 136.28, 136.29, 145.05, 145.83, 146.22. 
HRMS (EI) m/e calcd for C21H19NO 301.1468, found 301.1469. 
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9-isopropyl-1-methyl-3-phenyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (1-3a): See 
1-methyl-3,9-diphenyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (1-4a). 
1
H NMR (400 MHz, CD3CN) δ 7.62-7.58 (m, 2H), 7.48 (d, J = 7.8 Hz, 1H), 7.44-7.39 
(m, 2H), 7.28-7.23 (m, 2H), 7.13 (d, J = 7.8 Hz, 1H), 7.09 (dd, J = 5.5, 1.8 Hz, 1H), 6.98 (d, 
J = 5.5 Hz, 1H), 5.72 (d, J = 1.8 Hz, 1H), 3.93 (s, 3H), 3.27 (septet, J = 6.8 Hz, 1H), 1.14 
(dd, J = 1.8, 6.8 Hz, 6H).   
13
C NMR (100 MHz, CD3CN) δ 18.93, 19.06, 30.06, 37.76, 82.64, 100.26, 114.15, 
116.44, 117.15, 126.77, 128.29, 128.39, 129.72, 131.29, 134.48, 134.90, 136.39, 146.12, 
146.47, 149.32.  
HRMS (EI) m/e calcd for C22H21NO 315.1624, found 315.1624. 
6-isopropyl-1-methyl-3-phenyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (1-3b): 
1
H NMR (400 MHz, C6D6) δ 7.73-7.68 (m, 3H), 7.38-7.32 (m, 2H), 7.21-7.17 (m, 1H), 
7.12 (d, J = 0.5 Hz, 1H), 6.76-6.75 (m, 2H), 6.53 (s, 1H), 5.92 (s, 1H), 2.82 (s, 3H), 2.67 
(septet, J = 6.8 Hz, 1H), 1.36 (dd, J = 8.7, 6.8 Hz, 6H).  
13
C NMR (100 MHz, THF-d8) δ 18.61, 18.76, 28.32, 35.32, 80.99, 97.93, 114.38, 
116.04, 116.92, 126.58, 127.89, 129.74, 129.89, 130.07, 133.42, 135.95, 136.65, 145.72, 
146.29, 146.51.  
HRMS (EI) m/e calcd for C22H21NO 315.1624, found 315.1622. 
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 1-methyl-3,9-diphenyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (1-4a): Use the 
standard procedure as 1-methyl-3-phenyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (22.2), 
except for using PhMe as the solvent instead of Et2O. 
1
H NMR (400 MHz, C6D6) δ 8.03 (d, J = 7.9 Hz, 1H), 7.70-7.65 (m, 2H), 7.37-7.31 (m, 
4H), 7.21-7.17 (m, 1H), 7.07-6.97 (br, 4H), 6.50 (s, 1H), 5.99 (dd, J = 3.6, 1.3 Hz, 1H), 
4.57(d, J = 3.7 Hz, 1H), 2.60-2.53 (m, 1H), 2.52 (s, 3H).   
13
C NMR (100 MHz, C6D6) δ 30.24, 83.10, 107.37, 114.23, 116.92, 117.87, 126.11, 
129.32, 129.38, 129.66, 130.13, 130.45, 131.38, 131.57, 132.18, 135.61, 135.24, 135.89, 
142.31, 146.20, 146.92.  
HRMS (EI) m/e calcd for C25H19NO 349.1468, found 349.1470. 
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9-(tert-butyl)-3-methyl-1-phenyl-6,9-dihydro-3H-6,9-epoxybenzo[e]indole (33.1a): 
See 1-methyl-3,9-diphenyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (1-4a).  
1
H NMR (400 MHz, CD3CN) δ 7.50 (d, J = 7.2 Hz, 1H), 7.40 (s, 1H), 7.35-7.25 (m, 2H), 
7.21 (d, J = 7.9 Hz, 1H), 7.10 (dd, J = 5.5, 1.7 Hz, 1H), 7.06-7.01 (m, 3H), 6.96 (d, J = 5.5 
Hz, 1H), 5.61 (d, J = 1.7 Hz, 1H), 3.73 (s, 3H), 0.73 (s, 9H). 
13
C NMR (100 MHz, C6D6) δ 27.78, 33.16, 33.49, 81.82, 104.92, 106.02, 114.97, 
116.32, 124.21, 127.71, 128.50, 128.81, 133.19, 138.31, 139.34, 142.68, 145.32, 145.76, 
147.19.  
HRMS (EI) m/e calcd for C23H23NO 329.1781, found 329.1780.  
6-(tert-butyl)-3-methyl-1-phenyl-6,9-dihydro-3H-6,9-epoxybenzo[e]indole (33.1b): 
1
H NMR (400 MHz, CD3CN) δ 7.50-7.45 (m, 4H), 7.44 (d, J = 8.2 Hz, 1H), 7.34-7.29 
(m, 1H), 7.26 (s, 1H), 7.22 (dd, J = 5.5, 1.8 Hz, 1H), 7.18 (d, J = 5.5 Hz, 1H), 6.96 (d, J = 8.2 
Hz, 1H), 5.79 (d, J = 1.7 Hz, 1H), 3.76 (s, 3H), 1.27 (s, 9H). 
13
C NMR (100 MHz, C6D6) δ 27.91, 33.30, 33.66, 81.75, 104.11, 108.48, 115.00, 
116.78, 123.54, 127.60, 128.13, 128.81, 132.65, 133.48, 137.01, 139.6, 141.25, 145.82, 
148.19.  
HRMS (EI) m/e calcd for C23H23NO 329.1781, found 329.1781.  
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5-(tert-butyl)-1-methyl-3-phenyl-5,8-dihydro-1H-5,8-epoxybenzo[f]indole (33.2a): 
See 1-methyl-3,9-diphenyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (1-4a). 
1
H NMR (400 MHz, C6D6) δ 7.69 (d, J = 12.8 Hz, 1H), 7.56 (d, J = 8.4 Hz, 2H), 7.31 (t, 
J = 7.7 Hz, 2H), 7.15 (m, 3H), 6.57 (s, 1H), 6.12 (m, 1H), 5.16 (m, 1H), 3.46 (s, 3H), 1.48 (s, 
9H).   
13
C NMR (100 MHz, C6D6) δ 27.01, 31.96, 33.11, 81.86, 99.34, 104.74, 110.12, 111.77, 
117.67, 122.93, 125.84, 125.93, 129.06, 134.93, 136.59, 142.03, 143.80, 144.21, 144.97. 
HRMS (EI) m/e calcd for C23H23NO 329.1781, found 329.1782. 
8-(tert-butyl)-1-methyl-3-phenyl-5,8-dihydro-1H-5,8-epoxybenzo[f]indole (33.2b):  
1
H NMR (400 MHz, C6D6) δ 7.68 (d, J = 9.3 Hz, 1H), 7.60 (d, J = 7.1 Hz, 2H), 7.30 (t, J 
= 7.5 Hz, 2H), 7.15 (m, 3H), 6.62 (s, 1H), 6.27 (d, J = 3.7 Hz, 1H), 5.29 (m, 1H), 3.06 (s, 3 
H), 1.17 (s, 9H).   
13
C NMR (100 MHz, C6D6) δ 26.99, 32.08, 33.06, 81.72, 99.50, 102.78, 113.58, 118.22, 
123.15, 125.69, 126.02, 128.65, 129.16, 134.68, 136.64, 141.06, 143.13, 143.83, 146.96.   
HRMS (EI) m/e calcd for C23H23NO 329.1781, found 329.1781. 
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 6,7-dibromo-4-ethyl-1H-indole (35.1): In a 1.0 L round-bottom flask was dissolved 
9.77 g (31.6 mmol) 1,2-dibromo-5-ethyl-3-nitrobenzene (44.2) in 235 mL dry THF. The 
solution was cooled to -40 °C (dry ice/chlorobenzene) with stirring under nitrogen. To the 
cold solution was added 95 mL (95 mmol) of a 1.0 M solution of vinylmagnesium bromide 
in THF rapidly and in one portion. The mixture was stirred at -40 °C for 30 min, then 100 
mL saturated ammonium chloride was added and the mixture subsequently was allowed to 
warm to room temperature. The mixture was then extracted with diethyl ether (3 x 100 mL), 
the combined organic phase was then washed with water (100 mL) and brine (50 mL), dried 
over anhydrous magnesium sulfate, filtered and concentrated under reduced pressure. The 
crude material was purified via column chromatography on silica gel using 15% ethyl acetate 
in hexanes as eluent to give 4.98 g (52%) of the title compound as an orange oil.  
1
H NMR (400 MHz, CDCl3) δ 8.35 (bs, 1H, NH), 7.21 (dd, J = 3.1, 0.8 Hz, 1H), 7.19 (s, 
1H), 6.64 (dd, J = 2.1, 1.1 Hz, 1H), 2.87 (q, J = 7.6 Hz, 2H), 1.34 (t, J = 7.5 Hz, 3H).  
13
C NMR (100 MHz, CDCl3) δ 137.1, 135.3, 126.7, 124.6, 123.1, 117.3, 104.2, 102.5, 
25.8, 14.5. 
HRMS (EI) m/e calcd for C10H9Br2N 300.9102, found 300.9099. 
 
106 
 
6,7-dibromo-4-ethyl-1-methyl-1H-indole (35.9):  
See 5,6-Dichloro-1-methyl-3-phenyl-1H-indole (18.6). 
 
1
H NMR (400 MHz, CDCl3) δ 7.15 (s, 1H), 6.95 (d, J = 3.2 Hz, 1H), 6.43 (d, J = 3.2 Hz, 
1H), 4.13 (s, 3H), 2.80 (q, J = 7.6 Hz, 2H), 1.28 (t, J = 7.6 Hz, 3H). 
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4-ethyl-1-methyl-6,9-dihydro-1H-6,9-methanobenzo[g]indole (35.11): 
See (±)-1-(tert-butyldimethylsilyl)-4-ethyl-6,9-dihydro-1H-6,9-methanobenzo[g]indole 
(45.1). 
1
H NMR (400 MHz, CDCl3) δ 6.98 (s, 1H), 6.91-6.87 (m, 2H), 6.86-6.82 (m, 1H), 6.41 
(d, J = 3.2 Hz, 1H), 4.49 (d, J = 2.3 Hz, 1H), 3.98 (s, 1H), 3.93 (s, 3H), 2.90-2.82 (m, 2H), 
2.42-2.33 (m, 2H), 1.31 (t, J = 7.6 Hz, 3H). 
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1-methyl-6-(2-methylenebut-3-en-1-yl)-3-phenyl-1H-indole (36.1):   
See 1-methyl-3,9-diphenyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (1-4a).  
1
H NMR (400 MHz, CDCl3) δ 7.83 (d, J = 8.2 Hz, 1H), 7.66-7.60 (m, 2H), 7.44-7.37 (m, 
2H), 7.26-7.20 (m, 1H), 7.18-7.15 (m, 2H), 7.04 (dd, J = 8.2, 1.5 Hz, 1H), 6.46 (dd, J = 17.5, 
11.2 Hz, 1H), 5.31 (d, J = 17.6 Hz, 1H), 5.18 (s, 1H), 5.06 (d, J = 10.8 Hz, 1H), 4.95 (s, 1H), 
3.79 (s, 3H), 3.71 (s, 2H). 
13
C NMR (100 MHz, CDCl3) δ 146.12, 138.85, 138.09, 135.98, 133.71, 128.91, 128.87, 
127.43, 126.43, 125.81, 121.73, 119.88, 118.25, 114.49, 110.02, 109.69, 38.69, 33.05. 
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1-methyl-6-(3-methyl-2-methylenebut-3-en-1-yl)-3-phenyl-1H-indole (36.2):  
See 1-methyl-3,9-diphenyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (1-4a).  
1
H NMR (400 MHz, CDCl3) δ 7.83 (d, J = 8.2 Hz, 1H), 7.67-7.60 (m, 2H), 7.44-7.37 (m, 
2H), 7.28-7.20 (m, 1H), 7.19-7.14 (m, 2H), 7.04 (dd, J = 8.2, 1.4 Hz, 1H), 5.29 (s, 1H), 5.19 
(s, 1H), 4.98 (s, 1H), 4.94 (s, 1H), 3.79 (s, 3H), 3.78 (s, 2H), 1.95 (s, 3H). 
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6-(5-isopropyl-2-methylcyclohexa-2,5-dien-1-yl)-1-methyl-3-phenyl-1H-indole 
(36.3a) and  
6-(2-isopropyl-5-methylcyclohexa-2,5-dien-1-yl)-1-methyl-3-phenyl-1H-indole 
(36.3b): 
See 1-methyl-3,9-diphenyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (1-4a). These two 
isomers couldn’t be separated and the ratio was based on NMR analysis.  
1
H NMR (400 MHz, CDCl3) δ 8.04-7.86 (m, 1H), 7.79-7.65 (m, J = 1.3 Hz, 2H), 7.56- 
7.42 (m, 2H), 7.38-7.26 (m, 1H), 7.21 (s, 2H), 7.16-7.04 (m, 1H), 5.86-5.52 (m, 2H), 4.36- 
3.89 (m, 1H), 3.82 (s, 3H), 3.07-2.00 (m, 2H), 1.87-1.59 (m, 3H), 1.59-1.26 (m, 1H), 1.25- 
0.88 (m, 6H). 
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9-(tert-butyl)-1-methyl-3-phenyl-1H-benzo[g]indol-6(9H)-one (39.1): In a 50 mL 
round-bottom flask was added a solution of 10 mg (0.030 mmol) 
9-(tert-butyl)-1-methyl-3-phenyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole 32.2a in 22 mL 
CH2Cl2/MeOH (10:1). The solution was bubbled with N2 for 30 min then lifted the needle 
right above the liquid surface. To the stirred solution was added one crystal of AlCl3 (cat.) 
and kept stirring for another 3 hours. Then to the mixture was added 20 mL NaOH solution 
(0.5 N) and stirred for 10 min, followed by extraction with Et2O. The organic phases were 
separated and washed with brine and dried over anhydrous magnesium sulfate, filtered and 
concentrated under reduced pressure. The crude material was purified by silica gel column, 
eluting with toluene to give 9.2 mg (92%) of the title compound as a yellow oil.  
1
H NMR (400 MHz, C6D6) δ 8.57 (d, J = 8.4 Hz, 1H), 7.91 (d, J = 8.4 Hz, 1H), 7.62- 
7.54 (m, 2H), 7.36-7.27 (m, 2H), 7.23-7.13 (m, 1H), 6.73-6.64 (m, 2H), 6.62 (s, 1H), 3.77 (d, 
J = 5.2 Hz, 1H), 3.02 (s, 3H), 0.60 (s, 9H). 
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1-methyl-3-phenyl-1H-benzo[g]indole-6,9-dione (40.1): In a 50 mL round-bottom 
flask was added a solution of 10 mg (0.030 mmol) 
9-(tert-butyl)-1-methyl-3-phenyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole 32.2a in 22 mL 
CH2Cl2/MeOH (10:1). To the stirred solution was added one crystal of PPTS (cat.) and kept 
stirring for another 3 hours. Then to the mixture was added 20 mL NaOH solution (0.5 N) 
and stirred for 10 min, followed by extraction with Et2O. The organic phases were separated 
and washed with brine and dried over anhydrous magnesium sulfate, filtered and 
concentrated under reduced pressure. The crude material was purified by silica gel column, 
eluting with toluene to give 3.2 mg (38%) of the title compound as a yellow oil.  
1
H NMR (400 MHz, CDCl3) δ 8.14 (d, J = 8.3 Hz, 1H), 7.92 (d, J = 8.3 Hz, 1H), 7.58- 
7.52 (m, 2H), 7.49-7.42 (m, 2H), 7.38 (s, 1H), 7.36-7.30 (m, 1H), 6.89 (d, J = 0.8 Hz, 2H), 
4.06 (s, 3H). 
13
C NMR (100 MHz, CDCl3) δ 186.35, 185.86, 139.72, 137.30, 135.43, 134.37, 134.27, 
133.75, 129.18, 128.91, 128.22, 127.03, 125.64, 119.89, 118.89, 118.53, 40.02. 
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1-methyl-3-phenyl-1H-benzo[g]indol-6-ol (40.2):  
In a 50 mL round-bottom flask was added a solution of 10 mg (0.030 mmol) 
9-(tert-butyl)-1-methyl-3-phenyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole 32.2a in 22 mL 
CH2Cl2/MeOH (10:1). To the stirred solution was added one crystal of TsOH (cat.) and kept 
stirring for another 3 hours. Then to the mixture was added 20 mL NaOH solution (0.5 N) 
and stirred for 10 min, followed by extraction with Et2O. The organic phases were separated 
and washed with brine and dried over anhydrous magnesium sulfate, filtered and 
concentrated under reduced pressure. The crude material was purified by silica gel column, 
eluting with toluene to give 7.9 mg (97%) of the title compound as a yellow oil.  
1
H NMR (400 MHz, CDCl3) δ 8.10 (d, J = 8.6 Hz, 1H), 7.98 (d, J = 9.0 Hz, 1H), 7.91 (d, 
J = 9.0 Hz, 1H), 7.70-7.62 (m, 2H), 7.50-7.42 (m, 2H), 7.37 (dd, J = 8.5, 7.6 Hz, 1H), 7.32- 
7.26 (m, 1H), 7.20 (s, 1H), 6.84 (dd, J = 7.6, 0.8 Hz, 1H), 5.42 (s, 1H), 4.31 (s, 3H). 
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6,7-dibromo-4,5-dimethyl-1H-indole (43.4): See 6,7-dibromo-4-ethyl-1H-indole 
(35.1). 
1
H NMR (400 MHz, CDCl3) δ 8.22 (s, 1H), 7.19 (dd, J = 2.4, 3.2 Hz, 1H), 6.57 (dd, J = 
2.0, 3.2 Hz, 1H), 2.53 (s, 3H), 2.49 (s, 3H).  
13
C NMR (100 MHz, CDCl3) δ 133.5, 128.1, 128.0, 127.9, 124.4, 121.0, 104.8, 102.4, 
20.8, 17.0.  
HRMS (EI) m/e calcd for C10H9Br2N 300.9102, found 300.9100. 
Mp = 125-127 °C. 
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6,7-dibromo-4-ethyl-5-methyl-1H-indole (43.7): See 6,7-dibromo-4-ethyl-1H-indole 
(35.1). 
1
H NMR (400 MHz, CDCl3) δ 8.24 (s, 1H), 7.19 (dd, J = 3.2, 2.4 Hz, 1H), 6.58 (dd, J = 
3.2, 2.2 Hz, 1H), 2.94 (q, J = 7.6 Hz, 2H), 2.54 (s, 3H), 1.20 (t, J = 7.6 Hz, 3H). 
13
C NMR (100 MHz, CDCl3) δ 134.73, 134.09, 127.52, 127.43, 124.73, 121.72, 105.36, 
102.49, 24.75, 20.51, 14.56. 
116 
 
 4-ethyl-2-nitroaniline (44.1): In a 250 mL round-bottom flask was added 11.73 g (115 
mmol) acetic anhydride and 105 mL 1,2-dichloroethane. To this was added 12.1 g (100 
mmol) 4-ethylaniline (43.2) and the solution was heated to 80 °C for 1 h. The solution was 
then cooled to 50 °C and 10.1 mL (240 mmol) of fuming nitric acid was added dropwise over 
45 min. The solution was then stirred at 45-50 °C for 1 h. To the solution was then added 13 
g (325 mmol) of sodium hydroxide dissolved in a minimum volume of water over a 10 min 
period. The temperature was raised to above 80 °C and the 1,2-dichloroethanewas distilled 
out of the reaction mixture, after which point the temperature was raised to between 95 and 
97 °C and the reaction was monitored by TLC. After 5 h, TLC analysis showed complete 
hydrolysis of the intermediate amide and the mixture was cooled to room temperature. The 
crude reaction mixture was extracted with ethyl acetate (3 x 100 mL), the organic layer was 
then washed with brine (1 x 50 mL), dried over anhydrous sodium sulfate, filtered and 
concentrated under reduced pressure to give 15.85 g (96%) of the title compound as an 
orange crystalline solid.  
1
H NMR (400 MHz, CDCl3) δ 7.88 (s, H), 7.18 (dd, J = 6.4, 2.1 Hz, 1H), 6.72 (d, J = 8.4 
Hz, 1H), 5.96 (bs, 2H, NH2), 2.52 (q, J = 7.6 Hz, 2H), 1.17 (t, J = 7.6 Hz, 3H).  
13
C NMR (100 MHz, CDCl3) δ 142.9, 136.1, 133.0, 131.9, 124.0, 118.8, 27.4, 15.2.  
117 
HRMS (EI) m/e calcd for C8H10N2O2 166.0742, found 166.0744. 
Mp = 34-36 °C. 
 
 
 
 
 
 
 
 
 
 
 
 
 
118 
 
 1,2-dibromo-5-ethyl-3-nitrobenzene (44.2): In a 500 mL three-necked round-bottom 
flask was added 1.881 g (8.42 mmol) CuBr2. This was dissolved in 170 mL acetonitrile and 
the solution was heated to 50 °C. After 5 min, 18.17 g (113.7 mmol) of bromine dissolved in 
42 mL acetonitrile was added to the warm solution, followed by a solution of 7.0 g (42.12 
mmol) 4-ethyl-2-nitroaniline (44.1) in a minimum volume of acetonitrile. The mixture was 
stirred at 50 °C for 40 min, and then a solution of 5.21 g (50.5mmol) tert-butyl nitrite in 85 
mL acetonitrile was added to the reaction mixture dropwise over a period of 1 h. The mixture 
was then stirred at 50 °C for 30 min, and then cooled to room temperature. The reaction 
mixture was then quenched with 150 mL saturated sodium sulfite and subsequently poured 
into 800 mL 3 N HCl. The aqueous mixture was extracted with 800 mL diethyl ether once 
and 400 mL diethyl ether once. The combined organic layer was washed with 400 mL 3 N 
HCl, dried over anhydrous magnesium sulfate, filtered and concentrated under reduced 
pressure. The crude product was then passed through a plug of silica gel, eluting with 1:1 
hexane:ether to give 10.7 g (82%) of the title compound as a yellow oil which solidifies 
under 0 °C.  
1
H NMR (400 MHz, CDCl3) δ 7.67 (m, 1H), 7.45 (m, 1H), 2.66 (q, J = 7.6 Hz, 2H), 1.26 
(t, J = 7.6 Hz, 3H).  
119 
13
C NMR (100 MHz, CDCl3) δ 146.1, 136.0, 127.5, 123.0, 113.8, 27.9, 14.7.  
HRMS (EI) m/e calcd for C8H7Br2NO2 306.8844, found 306.8844. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
120 
 
 6,7-dibromo-1-(tert-butyldimethylsilyl)-4-ethyl-1H-indole (44.3): In a 500 mL 
three-necked round-bottom flask was dissolved 1.10 g (3.64 mmol) 
6,7-dibromo-4-ethyl-1H-indole (35.1) in 100 mL dry THF under nitrogen. The solution was 
cooled to -78 °C and to the flask was added 1.45 g (7.28 mmol) KHMDS. The resulting dark 
brown solution was stirred for 5 min, then 3.2 mL (14.56 mmol) of tert-butyldimethylsilyl- 
trifluoromethanesulfonate was added dropwise over 5 min via syringe. The resulting yellow 
solution was stirred at -78 °C for 30 min, after which time TLC analysis showed the reaction 
to be complete. A solution of 10 mL triethylamine in 200 mL ether was then added and the 
reaction mixture was allowed to warm to room temperature. The mixture was then poured 
into 200 mL ether and washed with 150 mL 0.5 N HCl, 150 mL water and 100 mL brine. The 
ether layer was then dried over anhydrous magnesium sulfate, filtered and concentrated 
under reduced pressure. The crude material was then purified via column chromatography on 
silica gel using hexanes as eluent to give 1.1 g (73%) of the title compound as a colorless oil. 
 
1
H NMR (400 MHz, CDCl3) δ 7.38 (d, J = 3.5 Hz, 1H), 7.27 (s, 1H), 6.66 (d, J =3.4 Hz, 
1H), 2.84 (q, J = 7.6 Hz, 2H), 1.31 (t, J = 7.6 Hz, 3H), 1.00 (s, 9H), 0.72 (s, 6H).  
13
C NMR (100 MHz, CDCl3) δ 140.7, 136.3, 134.2, 132.1, 124.1, 119.8, 105.7, 103.6, 
27.5, 25.8, 19.9, 14.4, 2.2.  
HRMS (EI) m/e calcd for C16H23Br2NSi 414.9967, found 414.9966. 
121 
 
(±)-1-(tert-butyldimethylsilyl)-4-ethyl-6,9-dihydro-1H-6,9-methanobenzo[g]indole 
(45.1): In a flame-dried 500 mL three-necked round-bottom flask was added a solution of 
1.84 g (4.41 mmol) 6,7-dibromo-1-(tert-butyldimethylsilyl)-4-ethyl-1H-indole 44.3 in 180 
mL dry toluene. To this was added 5.83 g (88.2 mmol) of freshly cracked cyclopentadiene. 
The resulting solution was cooled to -78 °C, then 3.53 mL (8.82 mmol) of a 2.5 M solution of 
n-butyllithium in hexanes was added dropwise via syringe over 15 min. The solution was 
stirred at -78 °C for 30 min then was allowed to slowly warm to room temperature. The 
reaction was then quenched by addition of 100 mL saturated ammonium chloride. After 
stirring for 5 min, the mixture was diluted with 200 mL water and extracted with 3 x 150 mL 
dichloromethane. The combined organic phase was dried over anhydrous magnesium sulfate, 
filtered and concentrated under reduced pressure. The crude material was then purified via 
column chromatography on silica gel using 5% dichloromethane in hexanes as eluent to give 
1.1 g (77%) of the title compound as a white solid. 
 
1
H NMR (400 MHz, CDCl3) δ 7.19 (d, J = 3.4 Hz, 1H), 7.06 (s, 1H), 6.95 (dd, J = 5.2, 
3.1 Hz, 1H), 6.86 (dd, J = 5.3, 2.7 Hz, 1H), 6.63 (d, J = 3.4 Hz, 1H), 4.51 (bs, 1H), 4.01 (bs, 
1H), 2.90 (q, J = 7.6 Hz, 2H), 2.35 (m, 2H), 1.36 (t, J = 7.6 Hz, 3H), 1.08 (s, 9H), 0.70 (s, 
3H), 0.61 (s, 3H).  
122 
13
C NMR (100 MHz, CDCl3) δ 147.3, 145.1, 142.3, 136.6, 131.9, 131.7, 131.2, 129.4, 
114.3, 103.2, 70.4, 51.2, 50.7, 26.7, 26.2, 19.4, 14.7, -1.5, -1.9.  
HRMS (EI) m/e calcd for C21H29NSi 323.2071, found 323.2069. 
Mp= 71-73 °C.  
 
 
 
 
 
 
 
 
 
 
123 
 
 (±)-1-(tert-butyldimethylsilyl)-4-ethyl-6,7,8,9-tetrahydro-1H-6,9-methanobenzo[g]in
dole-7,8-diol (45.2): In a 20 mL vial was added 10 mg (0.031 mmol) 
(±)-1-(tert-butyldimethylsilyl)-6,9-dihydro-5-ethyl-6,9-methano-1H-benz[g]indole 45.1 and 
this was dissolved in 2.5 mL THF/water (1.5:1). To the solution was added 21 mg (0.155 
mmol) NMO hydrate. The mixture was stirred at room temperature, and 1 drop osmium 
tetroxide solution (4% in water) was added and the reaction was followed by TLC. After 
intervals of 1 h, another 2 drops osmium tetroxide solution was added and stirring continued 
until 6 h, at which time TLC showed complete reaction. The reaction mixture was quenched 
by addition of 2 mL saturated sodium bisulfite, and the subsequent mixture was stirred 
rapidly for 30 min. The mixture was then extracted with ethyl acetate (3 x 15 mL), and the 
combined organic phase was dried over anhydrous magnesium sulfate, filtered and 
concentrated under reduced pressure. The crude material was purified via column 
chromatography on silica gel using 30% ethyl acetate in hexanes as eluent to give 10 mg 
(88%) of the title compound as a white solid.  
1
H NMR (400 MHz, CDCl3) δ 7.22 (d, J = 3.5 Hz, 1H), 6.92 (s, 1H), 6.65 (d, J = 3.5 Hz, 
1H), 3.82 (m, 2H), 3.72 (bs, 1H), 3.27 (bs, 1H), 3.07 (bs, 1H, OH), 2.90 (q, J = 7.6 Hz, 2H), 
2.81 (bs, 1H, OH), 2.23 (m, 1H), 1.93 (m, 1H), 1.33 (t, J = 7.6 Hz, 3H), 1.02 (s, 9H), 0.71 (s, 
3H), 0.60 (s, 3H).  
124 
13
C NMR (100 MHz, CDCl3) δ 140.0, 135.8, 134.6, 131.4, 130.7, 125.5, 113.8, 103.3, 
71.7, 71.6, 50.8, 50.4, 42.4, 26.7, 26.3, 19.5, 14.6, -1.5, -1.9.  
HRMS (EI) m/e calcd for C21H31NO2Si 357.2125, found 357.2124. 
Mp = 165-166 °C. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
125 
 
 (±)-1-(tert-butyldimethylsilyl)-4-ethyl-1,6,7,8-tetrahydrocyclopenta[g]indole-6,8-dic
arbaldehyde (45.3): In a 250 mL round-bottom flask was added a solution of 120 mg (0.336 
mmol) (±)-1-(tertbutyldimethylsilyl)-6,7,8,9-tetrahydro-5-ethyl-7,8-dihydroxy-6,9-methano- 
1H-benz[g]indole 45.2 in 24 mL THF. To the stirred solution was added 7 mL water 
followed by 1.078 g (5.04 mmol) sodium periodate. The mixture was stirred at room 
temperature until TLC analysis indicated complete reaction, about 1 h. The mixture was 
diluted with 150 mL ethyl acetate and 150 mL water. The phases were separated and the 
organic layer was washed with brine (25 mL) and dried over anhydrous magnesium sulfate, 
filtered and concentrated under reduced pressure. The crude material was passed through a 
plug of silica gel, eluting with 40% ethyl acetate in hexanes to give 119 mg (100%) of the 
title compound as a brown solid.  
1
H NMR (400 MHz, CDCl3) δ 9.64 (s, 1H), 9.63 (s, 1H), 7.30 (d, J = 3.4 Hz, 1H), 7.04 
(s, 1H), 6.73 (d, J = 3.5 Hz, 1H), 4.52 (d, J = 9.3 Hz, 1H), 3.97 (d, J = 8.9 Hz, 1H), 3.00 (m, 
1H), 2.94 (q, J =7.6 Hz, 2H), 2.58 (dt, J = 9.3, 13.6 Hz, 1H), 1.35 (t, J = 7.6 Hz, 3H), 0.77 (s, 
9H), 0.63 (s, 3H), 0.62 (s, 3H).  
126 
13
C NMR (100 MHz, CDCl3) δ 201.1, 200.2, 138.8, 137.5, 134.0, 133.0, 132.9, 121.0, 
116.5, 104.2, 56.9, 56.8, 29.7, 27.6, 26.3, 20.2, 14.4, -1.3, -1.4.  
HRMS (EI) m/e calcd for C21H29NO2Si 355.1968, found 355.1966. 
Mp = 136-138 °C. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
127 
 
(±)-6,8-bis(bis(ethylthio)methyl)-4-ethyl-1,6,7,8-tetrahydrocyclopenta[g]indole (45.4):  
In a 50 mL flame-dried round-bottom flask under nitrogen was added a solution of 108 mg 
(0.304 mmol) (±)-1-(tert-butyldimethylsilyl)-4-ethyl-1,6,7,8-tetrahydrocyclopenta[g]indole- 
6,8-dicarbaldehyde 45.3 in 10 mL ethanethiol. This solution was cooled to -78 °C, then 4 
drops of BF3⋅OEt2 was added and the mixture was stirred at -78 °C for 15 min. The solution 
was then warmed to room temperature and followed by TLC. After a further 45 min, 
saturated sodium bicarbonate (20 mL) was added, and the mixture was extracted with 
dichloromethane (3 x 50 mL). The combined organic layer was dried over anhydrous sodium 
sulfate, filtered and concentrated under reduced pressure. The crude material was purified via 
column chromatography on silica gel using 5% ethyl acetate in hexanes as eluent to give 98 
mg (71%) of the title compound as a pale purple oil.  
1
H NMR (400 MHz, CDCl3) δ 10.14 (bs, 1H, NH), 7.22 (dd, J = 3.0, 2.6 Hz, 1H), 7.03 (s, 
1H), 6.57 (dd, J = 3.2, 2.1 Hz, 1H), 4.53 (d, J = 4.7 Hz, 1H), 4.25 (d, J = 3.8 Hz, 1H), 3.88 
(m, 1H), 3.75 (m, 1H), 2.99-2.47 (m, 12H), 1.41-1.32 (m, 9H), 1.27-1.21 (m, 6H).  
13
C NMR (100 MHz, CDCl3) δ 139.0 135.6, 132.5, 126.8, 123.0, 122.8, 114.6, 100.7, 
55.1, 54.8, 49.2, 48.3, 35.7, 27.0, 26.4, 26.3, 26.12, 26.09, 14.8, 14.6, 14.52, 14.50, 14.4.  
HRMS (EI) m/e calcd for C23H35NS4 453.1656, found 453.1655. 
128 
 
4,5-dimethyl-2-nitroaniline (46.1): See 4-ethyl-2-nitroaniline (44.1). The crude 
material was purified via column chromatography on silica gel using 10% EA in hexanes as 
eluent to remove the minor isomer 3,4-dimethyl-2-nitroaniline. 
1
H NMR (400 MHz, CDCl3) δ 7.84 (s, 1H), 6.57 (s, 1H), 5.89 (s, 2H), 2.20 (s, 3H), 2.15 
(s, 3H).  
13
C NMR (100 MHz, CDCl3) δ 146.6, 143.1, 130.1, 126.0, 125.5, 119.0, 20.0, 18.5. 
HRMS (EI) m/e calcd for C8H10N2O2 166.0742, found 166.0743. 
Mp = 135-137 °C.  
 
 
 
 
 
 
 
 
129 
 
 2,3-dibromo-4,5-dimethyl-1-nitrobenzene (46.2):  
See 1,2-dibromo-5-ethyl-3-nitrobenzene (44.2). 
1
H NMR (400 MHz, CDCl3) δ 7.46 (s, 1H), 2.51 (s, 3H), 2.36 (s, 3H).  
13
C NMR (100 MHz, CDCl3) δ 149.3, 143.3, 138.0, 130.2, 124.4, 114.7, 22.1, 21.2. 
HRMS (EI) m/e calcd for C8H7Br2NO2 306.8844, found 306.8847. 
Mp = 82-84 °C. 
 
 
130 
 
 6,7-dibromo-1-(tert-butyldimethylsilyl)-4,5-dimethyl-1H-indole (46.3):  
See 6,7-dibromo-1-(tert-butyldimethylsilyl)-4-ethyl-1H-indole (44.3). 
1
H NMR (400 MHz, CDCl3) δ 7.35 (d, J = 3.6 Hz, 1H), 6.61 (d, J = 3.6 Hz, 1H), 2.53 (s, 
3H), 2.47 (s, 3H), 0.96 (s, 9H), 0.69 (s, 6H).  
13
C NMR (100 MHz, CDCl3) δ 139.0, 134.1, 133.1, 129.1, 127.5, 123.5, 106.5, 104.0, 
27.5, 21.5, 19.9, 17.1, 2.1.  
HRMS (EI) m/e calcd for C16H23Br2NSi 414.9967, found 414.9965. 
Mp = 112-114 °C. 
 
 
131 
 
(±)-1-(tert-butyldimethylsilyl)-4,5-dimethyl-6,9-dihydro-1H-6,9-methanobenzo[g]in
dole (47.1):  
See (±)-1-(tert-butyldimethylsilyl)-4-ethyl-6,9-dihydro-1H-6,9-methanobenzo[g]indole 
(45.1). 
1
H NMR (400 MHz, CDCl3) δ 7.13 (d, J = 4.8 Hz, 1H), 6.92-6.91 (m, 1H), 6.85-6.84 (m, 
1H), 6.55 (d, J = 4.4 Hz, 1H), 4.49 (s, 1H), 4.17 (s, 1H), 2.42 (s, 3H), 2.38 (s, 3H), 2.31 (d, J 
= 8 Hz, 1H), 2.22 (d, J = 8 Hz, 1H), 1.03 (s, 9H), 0.66 (s, 3H), 0.58 (s, 3H).  
13
C NMR (100 MHz, CDCl3) δ 146.2, 144.7, 142.7, 134.9, 131.5, 131.3, 130.5, 123.3, 
122.4, 103.6, 69.6, 51.0, 49.2, 26.7, 19.5, 15.6, 15.3, -1.5, -1.8.  
HRMS (EI) m/e calcd for C21H29NSi 323.2071, found 323.2070. 
132 
 
(±)-1-(tert-butyldimethylsilyl)-4,5-dimethyl-6,7,8,9-tetrahydro-1H-6,9-methanobenz
o[g]indole-7,8-diol (47.2): See (±)-1-(tert-butyldimethylsilyl)-4-ethyl-6,7,8,9-tetrahydro-1H- 
6,9-methanobenzo[g]indole-7,8-diol (45.2). 
1
H NMR (400 MHz, CDCl3) δ 7.17 (d, J = 3.6 Hz, 1H), 6.58 (d, J = 3.6 Hz, 1H), 3.77 (s, 
2H), 3.72 (d, J = 1.6 Hz, 1H), 3.43 (d, J = 1.6 Hz, 1H), 3.20 (bs, 1H), 3.09 (bs, 1H), 2.42 (s, 
3H), 2.33 (s, 3H), 2.21 (dt, J = 9.6, 1.2 Hz, 1H), 1.88 (dt, J = 9.2, 1.6 Hz, 1H), 0.99 (s, 9H), 
0.69 (s, 3H), 0.58 (s, 3H).  
13
C NMR (100 MHz, CDCl3) δ 139.0, 133.9, 131.8, 131.4, 125.8, 125.1, 122.1, 103.6, 
71.6, 70.9, 50.7, 48.9, 41.9, 26.7, 19.5, 15.7, 15.2, -1.5, -1.9.   
HRMS (EI) m/e calcd for C21H31NO2Si 357.2125, found 357.2128. 
 
 
133 
 
(±)-1-(tert-butyldimethylsilyl)-4,5-dimethyl-1,6,7,8-tetrahydrocyclopenta[g]indole-6,
8-dicarbaldehyde (47.3): 
See (±)-1-(tert-butyldimethylsilyl)-4-ethyl-1,6,7,8-tetrahydrocyclopenta[g]indole-6,8- 
dicarbaldehyde (45.3). 
1
H NMR (400 MHz, CDCl3) δ 9.65 (s, 1H), 9.53 (d, J = 2.4 Hz, 1H), 7.26 (d, J = 3.6 Hz, 
1H), 6.67 (d, J = 3.6 Hz, 1H), 4.51 (d, J = 8.8 Hz, 1H), 4.04 (dd, J = 2.4, 8.8 Hz, 1H), 2.90 (d, 
J = 13.6 Hz, 1H), 2.60-2.53 (m, 1H), 2.47 (s, 3H), 2.29 (s, 3H), 0.75 (s, 9H), 0.61 (s, 3H), 
0.60 (s, 3H).  
13
C NMR (100 MHz, CDCl3) δ 201.1, 200.2, 137.0, 134.4, 133.7, 133.1, 128.9, 125.3, 
121.0, 104.5, 57.0, 56.3, 29.7, 28.5, 26.3, 20.3, 16.0, 15.9, 1.0, -1.2, -1.5. 
HRMS (EI) m/e calcd for C21H29NO2Si 355.1968, found 355.1968.    
 
134 
 
 6,8-bis(bis(ethylthio)methyl)-4,5-dimethyl-1,6,7,8-tetrahydrocyclopenta[g]indole 
(47.4): See (±)-6,8-bis(bis(ethylthio)methyl)-4-ethyl-1,6,7,8-tetrahydrocyclopenta[g]indole 
(45.4). 
1
H NMR (400 MHz, CDCl3) δ 10.02 (s, 1H), 7.16 (dd, J = 2.4, 3.2 Hz, 1H), 6.49 (dd, J = 
2.0, 2.8 Hz, 1H), 4.63-4.60 (m, 2H), 3.96-3.92 (m, 1H), 3.68-3.65 (m, 1H), 2.93-2.84 (m, 
1H), 2.80-2.70 (m, 3H), 2.67-2.57 (m, 2H), 2.45 (s, 3H), 2.40-2.36 (m, 1H), 2.34 (s, 3H), 
2.30-2.20 (m, 3H), 1.38-1.31 (m, 6H), 1.07 (t, J = 7.6 Hz, 6H).  
13
C NMR (100 MHz, CDCl3) δ 138.3, 131.7, 128.6, 127.6, 124.2, 123.2, 123.0, 100.9, 
56.3, 54.7, 50.3, 35.1, 31.6, 27.3, 26.6, 26.2, 25.5, 22.6, 16.2, 15.8, 14.8, 14.7, 14.5.  
HRMS (EI) m/e calcd for C23H35NS4 453.1656, found 453.1654.  
135 
 
N-(4-ethyl-3-methylphenyl)acetamide (48.2):
141
 4.50 g 48.1 was dissolved in 18.8 mL 
trifluoroacetic acid and then triethylsilane was added into the solution. The mixture was 
refluxed for 5 hours. Then the solution was cooled down to room temperature, followed by 
very slow addition of NaHCO3 saturation until evolution of gas had ceased and the solution 
remained alkaline. The mixture was then extracted with Et2O and the combined organic 
phase was dried over anhydrous magnesium sulfate, filtered and concentrated under reduced 
pressure, which gave the crude product containing lots of triethylsilane. The crude material 
was then washed and filtered with hexane several times to give 4.04 g (90%) of the title 
compound as a white solid. 
 
1
H NMR (400 MHz, CDCl3) δ 7.99 (s, 1H), 7.29-7.20 (m, 2H), 7.02 (d, J = 8.0 Hz, 1H), 
2.53 (q, J = 7.5 Hz, 2H), 2.20 (s, 3H), 2.10 (s, 3H), 1.13 (t, J = 7.5 Hz, 3H). 
 
13
C NMR (100 MHz, CDCl3) δ 169.59, 138.12, 135.87, 135.70, 127.86, 122.11, 118.24, 
25.45, 23.74, 18.91, 14.23. 
 
136 
  
4-ethyl-5-methyl-2-nitroaniline (48.3): In a 100 mL round-bottom flask was added 
23.4 mL 1,2-dichloroethane. To this was added 3.94 g (22.3 mmol) 
N-(4-ethyl-3-methylphenyl)acetamide (48.2)  and the solution was heated to 50 °C and 2.2 
mL (53.5 mmol) of fuming nitric acid was added dropwise over 1 hour. The solution was 
then stirred at 45-50 °C for 1 h. To the solution was then added 3.2 g (80 mmol) of sodium 
hydroxide dissolved in a minimum volume of water over a 10 min period. The temperature 
was raised to above 80 °C and the 1,2-dichloroethane was distilled out of the reaction 
mixture, after which point the temperature was raised to between 95 and 97 °C and the 
reaction was monitored by TLC. After TLC analysis showed complete hydrolysis of the 
intermediate amide, the mixture was cooled to room temperature. The crude reaction mixture 
was extracted with ethyl acetate (3 x 100 mL), the organic layer was then washed with brine 
(1 x 50 mL), dried over anhydrous sodium sulfate, filtered and concentrated under reduced 
pressure. The crude material was purified via column chromatography on silica gel using 
10% EA in hexanes as eluent to give 2.8 g (71%) of the title compound.  
1
H NMR (400 MHz, CDCl3) δ 7.85 (s, 1H), 6.57 (s, 1H), 5.90 (s, 2H), 2.50 (q, J = 7.5 
Hz, 2H), 2.23 (s, 3H), 1.18 (t, J = 7.5 Hz, 3H). 
13
C NMR (100 MHz, CDCl3) δ 146.28, 143.09, 132.24, 130.71, 124.25, 119.54, 25.13, 
19.74, 14.27. 
137 
 
2,3-dibromo-5-ethyl-4-methyl-1-nitrobenzene (48.4):   
See 1,2-dibromo-5-ethyl-3-nitrobenzene (44.2).  
1
H NMR (400 MHz, CDCl3) δ 7.46 (s, 1H), 2.71 (q, J = 7.5 Hz, 2H), 2.53 (s, 3H), 1.22 
(t, J = 7.5 Hz, 3H). 
13
C NMR (100 MHz, CDCl3) δ 144.00, 142.89, 130.91, 123.18, 114.99, 110.00, 27.82, 
21.77, 14.18. 
138 
 
 1,2,5-tribromo-3-nitrobenzene (50.2): In a 500 mL three-necked round-bottom flask 
was added 446 mg (2 mmol) CuBr2. This was dissolved in 40 mL acetonitrile and the 
solution was heated to 50 °C. After 5 min, 2.11 mL (41 mmol) of bromine dissolved in 10 
mL acetonitrile was added to the warm solution, followed by a solution of 1.38 g (10 mmol) 
2-nitroaniline (50.1) in a minimum volume of acetonitrile. The mixture was stirred at 50 °C 
for 2 hours; then a solution of 1.44 mL (12 mmol) t-butyl nitrite in 60 mL acetonitrile was 
added to the reaction mixture dropwise over a period of 1 h. The mixture was then stirred at 
50 °C for 1 hour; then cooled to room temperature. The reaction mixture was then quenched 
with 50 mL saturated sodium sulfite and subsequently poured into 300 mL 3 N HCl. The 
aqueous mixture was extracted with 300 mL diethyl ether once and 100 mL diethyl ether 
once. The combined organic layer was washed with 100 mL 3 N HCl, dried over anhydrous 
magnesium sulfate, filtered and concentrated under reduced pressure. The crude product was 
then passed through a plug of silica gel, eluting with 1:1 hexane/ether to give 2.08 g (58%) of 
the title compound as a brown solid.  
 
1
H NMR (400 MHz, CDCl3) δ 7.97 (d, J = 2.2 Hz, 1H), 7.75 (d, J = 2.2 Hz, 1H). 
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2,3,5-tribromoaniline (51.1): In a 50 mL round-bottom flask was added 
1,2,5-tribromo-3-nitrobenzene (1 g, 2.78 mmol) in 17 mL absolute ethanol. To this solution 
3.14 g SnCl2·2H2O (13.9 mmol, 5 eq) was added; then, the mixture was heated to 70 ºC and 
stirred for 1 hour at this temperature. After that, the solution was poured directly onto 111 g 
of ice. The aqueous phase was adjusted to pH 9 with 2 N NaOH and extracted with ether. 
The organic phase was dried over anhydrous magnesium sulfate, filtered and concentrated 
under reduced pressure to give 753 mg (82%) of the title compound as a yellow solid. 
1
H NMR (400 MHz, CDCl3) δ 7.13 (d, J = 2.1 Hz, 1H), 6.81 (d, J = 2.1 Hz, 1H). 
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 (2,3,5-tribromophenyl)hydrazine (51.2): In a 50 mL round-bottom flask was added 
2,3,5-tribromoaniline (1 g, 3.03 mmol) in small amount ether. To this solution 15 mL 
HCl/Et2O (2 M, 30 mmol, 10 eq) was added and the mixture was stirred for 1 hour. Then the 
white salts were filtered and washed with Et2O and dried by vacuum. Dissolved the dried 
white salts in 50 mL HCl (6 N) and kept it at 0
 
ºC. To this solution added 230 mg NaNO2 
(3.33 mmol, 1.1 eq) in minimum water dropwise. Kept stirring at 0
 
ºC for 30 min, then added 
2.05 g SnCl2·2H2O (9.09 mmol, 3 eq) (dissolved in 12 N HCl) dropwise into the solution and 
kept stirring at 0
 
ºC for 1 hour. After that, filtered the solution and got white solid. Kept 
stirring the white solid with a mix solvent of 2 N NaOH solution and TBME for 30 min; then 
separated the organic phase and dried over anhydrous magnesium sulfate, filtered and 
concentrated under reduced pressure to give 762 mg (73%) of the title compound as a yellow 
solid. 
1
H NMR (400 MHz, CDCl3) δ 7.25 (d, J = 2.2 Hz, 1H), 7.17 (d, J = 2.2 Hz, 1H), 5.93 (s, 
1H), 3.85 (s, 2H). 
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 4,6,7-tribromo-3-phenyl-1H-indole (51.3): See 6,7-dibromo-3-phenyl-1H-indole 
(20.7a). 
 
1
H NMR (400 MHz, CDCl3) δ 8.49 (s, 1H), 7.56 (s, 1H), 7.48-7.43 (m, 2H), 7.42-7.37 
(m, 3H), 7.20 (d, J = 2.5 Hz, 1H). 
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4,6,7-tribromo-1-methyl-3-phenyl-1H-indole (51.4):  
See 5,6-Dichloro-1-methyl-3-phenyl-1H-indole (18.6) 
1
H NMR (400 MHz, CDCl3) δ 7.55 (s, 1H), 7.43-7.34 (m, 5H), 6.99 (s, 1H), 4.19 (s, 
3H). 
13
C NMR (100 MHz, CDCl3) δ 134.99, 133.92, 133.27, 131.67, 128.64, 127.43, 127.18, 
126.60, 119.69, 118.37, 114.24, 106.47, 38.41. 
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 4-bromo-1-methyl-3-phenyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (51.5): In a 
flame-dried 25 mL round-bottom flask was added a solution of 44 mg (0.099 mmol) 
4,6,7-tribromo-1-methyl-3-phenyl-1H-indole (51.4) in 2 mL dry toluene. To this was added 
144 µL (1.98 mmol, 20 eq) of furan. The resulting solution was cooled to -78 °C, then 40 µL 
(0.099 mmol 1 eq) of a 2.5 M solution of n-butyllithium in hexanes was added dropwise via 
syringe over 15 min. The solution was stirred at -78 °C for 30 min then was allowed to 
slowly warm to room temperature. The reaction was then quenched by addition of 10 mL 
saturated ammonium chloride. After stirring for 5 min, the mixture was diluted with 10 mL 
water and extracted with 3 x 10 mL dichloromethane. The combined organic phase was dried 
over anhydrous magnesium sulfate, filtered and concentrated under reduced pressure. The 
crude material was then purified via column chromatography on silica gel using 15% EA in 
hexanes as eluent to give 31 mg (90%) of the title compound. 
 
1
H NMR (400 MHz, CDCl3) δ 7.43-7.39 (m, 2H), 7.36-7.31 (m, 4H), 7.12 (ddd, J = 
11.9, 5.5, 1.7 Hz, 2H), 6.93 (s, 1H), 6.28 (s, 1H), 5.82 (s, 1H), 3.91 (s, 3H). 
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4-bromo-8-butyl-1-methyl-3-phenyl-1H-benzo[g]indole (51.6a):  
See 4-bromo-1-methyl-3-phenyl-6,9-dihydro-1H-6,9-epoxybenzo[g]indole (51.5), except 
for using 2 eq n-BuLi instead of 1 eq n-BuLi. 
1
H NMR (400 MHz, CDCl3) δ 8.38 (d, J = 8.7 Hz, 1H), 7.66 (s, 1H), 7.60 (s, 1H), 7.51- 
7.45 (m, 2H), 7.40-7.32 (m, 4H), 7.00 (s, 1H), 4.30 (s, 3H), 2.81-2.74 (m, 2H), 1.73-1.62 (m, 
2H), 1.44-1.30 (m, 2H), 0.94 (t, J = 7.4 Hz, 3H). 
4-bromo-7-butyl-1-methyl-3-phenyl-1H-benzo[g]indole (51.6b):  
1
H NMR (400 MHz, CDCl3) δ 8.23 (s, 1H), 7.74 (d, J = 8.3 Hz, 1H), 7.67 (s, 1H), 7.48 
(dd, J = 7.8, 1.7 Hz, 2H), 7.40-7.32 (m, 3H), 7.29 (d, J = 8.3 Hz, 1H), 7.01 (s, 1H), 4.32 (s, 
3H), 2.86-2.77 (m, 2H), 1.76-1.65 (m, 2H), 1.40 (dd, J = 14.9, 7.4 Hz, 2H), 0.95 (t, J = 7.4 
Hz, 3H). 
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2,4-dibromo-6-nitroaniline (52.1) 
In a 1.0 L round-bottom flask 50.1 (13.8 g, 100 mmol) was dissolved in 200 mL 
CH2Cl2/MeOH (2:1). To this mixture was added a solution of Br2 (63.9 g, 4 eq) in 100 mL 
CH2Cl2 dropwise and stirred at rt for 1h. The reaction mixture was then quenched with 
saturated NaHCO3 and Na2S2O3. The aqueous mixture was extracted with ethyl acetate, dried 
over anhydrous magnesium sulfate, filtered and concentrated under reduced pressure to give 
29.59 g of the title compound 4,6-dibromo-2-nitroaniline 52.1. 
1
H NMR (400 MHz, CDCl3) δ 8.28 (d, J = 6.2 Hz, 1H), 7.80 (d, J = 6.4 Hz, 1H), 6.60 
(bs s, 2H, NH2).  
13
C NMR (100 MHz, CDCl3) δ 141.2, 140.8, 128.2 (2C), 112.7, 106.8.  
Mp = 127.8-129.3 ºC. 
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4,6,7-tribromo-1H-indole (52.2): See 6,7-dibromo-4-ethyl-1H-indole (35.1). 
1
H NMR (400 MHz, CDCl3) δ 8.46 (bs s, 1H, NH), 7.53 (s, 1H), 7.28 (m, 1H), 6.65 (m, 
1H).  
13
C NMR (100 MHz, CDCl3) δ 153.3, 128.2, 126.7, 125.7, 117.2, 114.1, 106.5, 104.7.  
Mp = 97.0-99.0 ºC.  
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4,6,7-tribromo-1-(tert-butyldimethylsilyl)-1H-indole (52.3): 
In a 100 mL three-necked round-bottom flask was added 10 mL DMF. To this was 
added 57.3 mg Et3N (0.57 mmol, 2 eq) and the mixture was cooled to 0 ºC. Then 27.2 mg 
sodium hydride (1.13 mmol, 4 eq) was added, followed by 100 mg 52.2 (0.28 mmol). The 
mixture was stirred at 0 ºC for 30 min, after that, a solution of 139.4 mg TBSOTf (0.57 
mmol, 2 eq) was added dropwise. The solution was strirred at 0 ºC for another 30 min. After 
quenched with water, the aqueous mixture was extracted with ethyl acetate, dried over 
anhydrous magnesium sulfate, filtered and concentrated under reduced pressure. The crude 
products were purified via column chromatography on silica gel to give 103.7 mg title 
compound. 
1
H NMR (400 MHz, CDCl3) δ 7.62 (s, 1H), 7.43 (d, J = 3.6 Hz, 1H), 6.71 (d, J = 3.3 Hz, 
1H), 0.99 (s, 9H), 0.73 (s, 6H).  
13
C NMR (100 MHz, CDCl3) δ 140.7, 135.4, 133.4, 127.6, 119.4, 113.7, 108.0, 106.2, 
27.4, 19.9, 2.2.  
Mp = 90.5-91.6 ºC. 
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 4-bromo-1-(tert-butyldimethylsilyl)-6,9-dihydro-1H-6,9-methanobenzo[g]indole 
(53.2): See 
(±)-1-(tert-butyldimethylsilyl)-4-ethyl-6,9-dihydro-1H-6,9-methanobenzo[g]indole (45.1) 
1
H NMR (400 MHz, CDCl3) δ 7.34 (s, 1H), 7.22 (d, J = 3.3 Hz, 1H), 6.92 (m, 1H), 6.84 
(m, 1H), 6.64 (d, J = 3.5 Hz, 1H), 4.48 (s, 1H), 3.98 (s, 1H), 2.36-2.26 (m, 2H), 1.04 (s, 9H), 
0.69 (s, 3H), 0.61 (s, 3H).  
13
C NMR (100 MHz, CDCl3) δ 148.6, 145.0, 142.0, 136.9, 134.2, 132.4, 130.8, 118.6, 
109.2, 105.4, 70.4, 51.0, 50.6, 26.6, 19.4, -1.5, -1.8.  
Mp = 114.1-115.2 ºC.  
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4-(4-methoxyphenyl)-6,9-dihydro-1H-6,9-methanobenzo[g]indole (55.1): A 5 mL 
vial was flame-dried, flowed with argon. To the vial was added Pd2(dba)3 (4.6 mg, 0.0044 
mmol, 4 mol%), t-Bu3P•HBF4 (5.1 mg, 0.018 mmol, 16 mol%) and p-MeOPhB(OH)2 (33.7 
mg, 0.22 mmol, 2.2 eq). Placed the vial under vacuum and flowed with argon. To the vial 
was added a solution of 41.6 mg 53.2 (0.11 mmol) and DIEA (0.24 mmol, 2.2 eq) in THF. 
Heated the solution to 60-70 ºC and stirred for 3 h. Then cooled it to room temperature and 
worked up as usual. A flash column chromatography purification gave 18.2 mg (57%) title 
compound. 
1
H NMR (400 MHz, CDCl3) δ 8.03 (bs, 1H), 7.30 (s, 1H), 7.20-7.14 (m, 1H), 6.91-6.72 
(m, 4H), 6.56-6.50 (m, 1H), 4.13 (s, 1H), 4.00 (s, 1H), 3.75 (s, 3H), 2.42-2.36 (m, 2H), 
2.35-2.30 (m, 2H). 
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N-(3,4-dimethylphenyl)-6,9-dihydro-1H-6,9-methanobenzo[g]indol-4-amine (56.1): 
In a 5 mL vial was added Pd2(dba)3 (4.3 mg, 0.0042 mmol, 4 mol%), t-Bu3P•HBF4 (4.9 
mg, 0.017 mmol, 16 mol%), Cs2CO3 (51.3 mg, 0.16 mmol, 1.5 eq) and 3,4-dimethylaniline 
(16 mg, 0.13 mmol, 1.2 eq). This vial was sealed and placed under vacuum, then flowed with 
argon. To the vial was added a solution of 39.4 mg 53.2 (0.11 mmol) in glyme, and then it 
was heated to 80-85 ºC for 24 h. The reaction was quenched with water and extracted with 
t-BuOMe. Organic layer was separated and dried over MgSO4, filtered, concentrated under 
vacuum. The crude material was then purified via column chromatography on silica gel using 
15% EA in hexanes as eluent to give 8.5 mg (27%) of the title compound. 
1
H NMR (400 MHz, CDCl3) δ 8.03 (bs, 1H), 7.30 (s, 1H), 7.19-7.14 (m, 1H), 7.08-6.79 
(m, 6H), 6.57-6.50 (m, 1H), 4.13 (s, 1H), 3.99 (s, 1H), 2.42-2.29 (m, 2H), 2.20 (s, 6H). 
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